1
|
Moreno I, Hernández T, Calvo E, Fudio S, Kahatt C, Martínez S, Iglesias JL, Calafati RO, Pérez-Ramos L, Montilla L, Zeaiter A, Lubomirov R. Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug-Drug Interaction Study. Mar Drugs 2024; 22:178. [PMID: 38667795 PMCID: PMC11050816 DOI: 10.3390/md22040178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Revised: 04/11/2024] [Accepted: 04/15/2024] [Indexed: 04/28/2024] Open
Abstract
This open-label, two-part, phase Ib drug-drug interaction study investigated whether the pharmacokinetic (PK) and safety profiles of lurbinectedin (LRB), a marine-derived drug, are affected by co-administration of itraconazole (ITZ), a strong CYP3A4 inhibitor, in adult patients with advanced solid tumors. In Part A, three patients were sequentially assigned to Sequence 1 (LRB 0.8 mg/m2, 1-h intravenous [IV] + ITZ 200 mg/day oral in Cycle 1 [C1] and LRB alone 3.2 mg/m2, 1 h, IV in Cycle 2 [C2]). In Part B, 11 patients were randomized (1:1) to receive either Sequence 1 (LRB at 0.9 mg/m2 + ITZ in C1 and LRB alone in C2) or Sequence 2 (LRB alone in C1 and LRB + ITZ in C2). Eleven patients were evaluable for PK analysis: three in Part A and eight in Part B (four per sequence). The systemic total exposure of LRB increased with ITZ co-administration: 15% for Cmax, area under the curve (AUC) 2.4-fold for AUC0-t and 2.7-fold for AUC0-∞. Co-administration with ITZ produced statistically significant modifications in the unbound plasma LRB PK parameters. The LRB safety profile was consistent with the toxicities described in previous studies. Co-administration with multiple doses of ITZ significantly altered LRB systemic exposure. Hence, to avoid LRB overexposure when co-administered with strong CYP3A4 inhibitors, an LRB dose reduction proportional to CL reduction should be applied.
Collapse
Affiliation(s)
- Irene Moreno
- START Madrid—Centro Integral Oncológico Clara Campal (CIOCC), Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain
| | - Tatiana Hernández
- START Madrid—FJD, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain
| | - Emiliano Calvo
- START Madrid—Centro Integral Oncológico Clara Campal (CIOCC), Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain
| | | | | | | | | | | | | | | | - Ali Zeaiter
- PharmaMar S.A., 28770 Colmenar Viejo, Spain (S.M.)
| | | |
Collapse
|
2
|
Martínez S, Albóniga OE, López-Huertas MR, Gradillas A, Barbas C. Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients Using a Multiplatform Mass Spectrometry-Based Metabolomics Approach. J Proteome Res 2024. [PMID: 38566450 DOI: 10.1021/acs.jproteome.3c00706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2024]
Abstract
Despite the recent and increasing knowledge surrounding COVID-19 infection, the underlying mechanisms of the persistence of symptoms for a long time after the acute infection are still not completely understood. Here, a multiplatform mass spectrometry-based approach was used for metabolomic and lipidomic profiling of human plasma samples from Long COVID patients (n = 40) to reveal mitochondrial dysfunction when compared with individuals fully recovered from acute mild COVID-19 (n = 40). Untargeted metabolomic analysis using CE-ESI(+/-)-TOF-MS and GC-Q-MS was performed. Additionally, a lipidomic analysis using LC-ESI(+/-)-QTOF-MS based on an in-house library revealed 447 lipid species identified with a high confidence annotation level. The integration of complementary analytical platforms has allowed a comprehensive metabolic and lipidomic characterization of plasma alterations in Long COVID disease that found 46 relevant metabolites which allowed to discriminate between Long COVID and fully recovered patients. We report specific metabolites altered in Long COVID, mainly related to a decrease in the amino acid metabolism and ceramide plasma levels and an increase in the tricarboxylic acid (TCA) cycle, reinforcing the evidence of an impaired mitochondrial function. The most relevant alterations shown in this study will help to better understand the insights of Long COVID syndrome by providing a deeper knowledge of the metabolomic basis of the pathology.
Collapse
Affiliation(s)
- Sara Martínez
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities. Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain
| | - Oihane E Albóniga
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities. Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain
- Asociación Centro de Investigación Cooperativa en Biociencias (CICbioGUNE), Bizkaia Science and Technology Park bld 800, 48160 Derio, Bizkaia, Spain
| | - María Rosa López-Huertas
- Unidad de Inmunopatología del SIDA, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain
| | - Ana Gradillas
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities. Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain
| | - Coral Barbas
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities. Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain
| |
Collapse
|
3
|
Rivera P, Torres A, Romero J, Alarcón Á, Martínez S, Arrieta MP, Rodríguez-Mercado F, Galotto MJ. Effect of Operational Variables on Supercritical Foaming of Caffeic Acid-Loaded Poly(lactic acid)/Poly(butylene adipate-co-terephthalate) Blends for the Development of Sustainable Materials. Polymers (Basel) 2024; 16:948. [PMID: 38611209 PMCID: PMC11013249 DOI: 10.3390/polym16070948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2024] [Revised: 03/03/2024] [Accepted: 03/25/2024] [Indexed: 04/14/2024] Open
Abstract
Expanded polystyrene will account for 5.3% of total global plastic production in 2021 and is widely used for food packaging due to its excellent moisture resistance and thermal insulation. However, some of these packages are often used only once before being discarded, generating large amounts of environmentally harmful plastic waste. A very attractive alternative to the conventional methods used for polymer processing is the use of supercritical carbon dioxide (scCO2) since it has mass-transfer properties adapted to the foam morphology, generating different path lengths for the diffusion of active compounds within its structure and can dissolve a wide range of organic molecules under supercritical conditions. The objective of this research was to evaluate the effect of operational variables on the process of caffeic acid (CA) impregnation and subsequent foaming of polylactic acid (PLA) as well as two PLA/poly(butylene-co-terephthalate-adipate) (PBAT) blends using scCO2. The results showed an increase in the degree of crystallinity of the CA-impregnated samples due to the nucleation effect of the active compound. On the other hand, SEM micrographs of both films and foams showed significant differences due to the presence of PBAT and its low miscibility with PLA. Finally, the results obtained in this work contribute to the knowledge of the important parameters to consider for the implementation of the impregnation and foaming process of PLA and PLA/PBAT blends with potential use in food packaging.
Collapse
Affiliation(s)
- Patricia Rivera
- Packaging Innovation Center (LABEN), Technology Faculty, Center for the Development of Nanoscience and Nanotechnology CEDENNA, University of Santiago de Chile (USACH), Santiago 9170201, Chile; (P.R.); (Á.A.); (S.M.); (F.R.-M.); (M.J.G.)
- Laboratory of Membrane Separation Processes (LabProSeM), Department of Chemical Engineering, Engineering Faculty, University of Santiago de Chile, Santiago 9170201, Chile;
| | - Alejandra Torres
- Packaging Innovation Center (LABEN), Technology Faculty, Center for the Development of Nanoscience and Nanotechnology CEDENNA, University of Santiago de Chile (USACH), Santiago 9170201, Chile; (P.R.); (Á.A.); (S.M.); (F.R.-M.); (M.J.G.)
| | - Julio Romero
- Laboratory of Membrane Separation Processes (LabProSeM), Department of Chemical Engineering, Engineering Faculty, University of Santiago de Chile, Santiago 9170201, Chile;
| | - Álvaro Alarcón
- Packaging Innovation Center (LABEN), Technology Faculty, Center for the Development of Nanoscience and Nanotechnology CEDENNA, University of Santiago de Chile (USACH), Santiago 9170201, Chile; (P.R.); (Á.A.); (S.M.); (F.R.-M.); (M.J.G.)
- Laboratory of Membrane Separation Processes (LabProSeM), Department of Chemical Engineering, Engineering Faculty, University of Santiago de Chile, Santiago 9170201, Chile;
| | - Sara Martínez
- Packaging Innovation Center (LABEN), Technology Faculty, Center for the Development of Nanoscience and Nanotechnology CEDENNA, University of Santiago de Chile (USACH), Santiago 9170201, Chile; (P.R.); (Á.A.); (S.M.); (F.R.-M.); (M.J.G.)
| | - Marina P. Arrieta
- Departamento de Ingeniería Química Industrial y del Medio Ambiente, Escuela Técnica Superior de Ingenieros Industriales, Universidad Politécnica de Madrid (ETSII-UPM), Calle José Gutiérrez Abascal 2, 28006 Madrid, Spain;
- Grupo de Investigación, Polímeros, Caracterización y Aplicaciones (POLCA), 28006 Madrid, Spain
| | - Francisco Rodríguez-Mercado
- Packaging Innovation Center (LABEN), Technology Faculty, Center for the Development of Nanoscience and Nanotechnology CEDENNA, University of Santiago de Chile (USACH), Santiago 9170201, Chile; (P.R.); (Á.A.); (S.M.); (F.R.-M.); (M.J.G.)
| | - María José Galotto
- Packaging Innovation Center (LABEN), Technology Faculty, Center for the Development of Nanoscience and Nanotechnology CEDENNA, University of Santiago de Chile (USACH), Santiago 9170201, Chile; (P.R.); (Á.A.); (S.M.); (F.R.-M.); (M.J.G.)
| |
Collapse
|
4
|
Plaza V, Trigueros JA, Carretero JA, Ojanguren Arranz I, Vega Chicote JM, Almonacid Sánchez C, Bartra Tomás J, Cisneros Serrano C, Domínguez Juncal L, Domínguez-Ortega J, Figueroa Rivero J, Soto Campos JG, Macías Fernández E, Martínez S, Montoro Lacomba J, Quirce S. The use of triple therapy in asthma. The GEMA-FORUM V task force. J Investig Allergol Clin Immunol 2024; 34:0. [PMID: 38334050 DOI: 10.18176/jiaci.0975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2024] Open
Affiliation(s)
- V Plaza
- Director del Comité Ejecutivo de la Guía Española para el Manejo del Asma (GEMA). Servei de Pneumologia i Al·lèrgia. Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau). Universitat Autònoma de Barcelona.Barcelo
| | - J A Trigueros
- Medicina de Familia. Centro de Salud Buenavista. Toledo, Spain
| | - J A Carretero
- Servicio de Neumología. Hospital Royo Villanova. Zaragoza, Spain
| | - I Ojanguren Arranz
- Servicio de Neumología. Hospital Universitari Vall d´Hebron. Barcelona, Spain
| | - J M Vega Chicote
- UGC de Alergología. Hospital Regional Universitario. Málaga, Spain
| | - C Almonacid Sánchez
- Servicio de Neumología. Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
| | - J Bartra Tomás
- Servicio de Neumología y Alergia. Hospital Clínic de Barcelona. Barcelona, Spain
| | - C Cisneros Serrano
- Servicio de Neumología. Hospital Universitario de La Princesa. Instituto de Investigación La Princesa. Madrid, Spain
| | - L Domínguez Juncal
- Servicio de Neumología. Complejo Hospitalario Universitario A Coruña (CHUAC). A Coruña, Spain
| | - J Domínguez-Ortega
- Servicio de Alergología. Hospital Universitario La Paz. Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) y CIBER de Enfermedades Respiratorias (CIBERES). Madrid, Spain
| | - J Figueroa Rivero
- Sección de Alergología. Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria. Las Palmas, Spain
| | - J G Soto Campos
- UGC de Neumología y Alergia. Hospital Universitario de Jerez. Jerez de la Frontera, Spain
| | - E Macías Fernández
- Servicio de Neumología. Hospital Clínico Universitario de Valladolid. Valladolid, Spain
| | - S Martínez
- Servicio de Neumología. Hospital Comarcal de la Vega Baja. Alicante, Spain
| | - J Montoro Lacomba
- Servicio de Alergología. Hospital Arnau de Vilanova-Liria. Valencia, Spain
| | - S Quirce
- Servicio de Alergología. Hospital Universitario La Paz. Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) y CIBER de Enfermedades Respiratorias (CIBERES). Madrid, Spain
| |
Collapse
|
5
|
Faba S, Arrieta MP, Romero J, Agüero Á, Torres A, Martínez S, Rayón E, Galotto MJ. Biodegradable nanocomposite poly(lactic acid) foams containing carvacrol-based cocrystal prepared by supercritical CO 2 processing for controlled release in active food packaging. Int J Biol Macromol 2024; 254:127793. [PMID: 37926308 DOI: 10.1016/j.ijbiomac.2023.127793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2023] [Revised: 10/15/2023] [Accepted: 10/29/2023] [Indexed: 11/07/2023]
Abstract
Compounds derived from essential oils have been used in active packaging, but their volatility and degradability negatively affect stability and leads to high release rates. The present study aimed to develop PLA bionanocomposite foams loaded with carvacrol cocrystal by supercritical CO2 and its release into a food simulant for control release in food packaging. For this purpose, 4,4'-bipyridine was used as coformer and carvacrol as active agent. Cocrystallized closed cell foams were obtained using supercritical CO2 and were characterized in terms of their physicochemical and mechanical properties, and release kinetics to a D1 simulant were evaluated as well as the antioxidant ability. A better overall mechanical behavior due to the nanoclay promoting a higher interfacial adhesion with the polymeric matrix was revealed. A higher incorporation of carvacrol was observed in samples with higher C30B content. The incorporated cocrystals showed a decrease of one order of magnitude in the estimated effective diffusion coefficient of carvacrol and showed antioxidant activity. These results suggest that the nanocomposite foam containing carvacrol-based cocrystals could be used in active packaging systems with controlled release characteristics, especially with highly volatile compounds, and can be proposed for other fields such as biomedical applications.
Collapse
Affiliation(s)
- Simón Faba
- Packaging Innovation Center (LABEN), Department of Food Science and Technology, Faculty of Technology, Center for the Development of Nanoscience and Nanotechnology (CEDENNA), University of Santiago de Chile (USACH), Santiago 9170201, Chile.
| | - Marina P Arrieta
- Departamento de Ingeniería Química Industrial y del Medio Ambiente, Escuela Técnica Superior de Ingenieros Industriales, Universidad Politécnica de Madrid (ETSII-UPM), Calle José Gutiérrez Abascal 2, 28006 Madrid, Spain; Grupo de Investigación: Polímeros, Caracterización y Aplicaciones (POLCA), 28006 Madrid, Spain
| | - Julio Romero
- Laboratory of Membrane Separation Processes (LabProSeM), Department of Chemical Engineering and Bioprocesses, Engineering Faculty, University of Santiago de Chile (USACH), 9170201 Santiago, Chile
| | - Ángel Agüero
- Departamento de Ingeniería Química Industrial y del Medio Ambiente, Escuela Técnica Superior de Ingenieros Industriales, Universidad Politécnica de Madrid (ETSII-UPM), Calle José Gutiérrez Abascal 2, 28006 Madrid, Spain; Institut de Tecnologia de Materials (ITM), Universitat Politècnica de València (UPV), Plaza Ferrándiz y Carbonell 1, 03801 Alcoy, Spain
| | - Alejandra Torres
- Packaging Innovation Center (LABEN), Department of Food Science and Technology, Faculty of Technology, Center for the Development of Nanoscience and Nanotechnology (CEDENNA), University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - Sara Martínez
- Packaging Innovation Center (LABEN), Department of Food Science and Technology, Faculty of Technology, Center for the Development of Nanoscience and Nanotechnology (CEDENNA), University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - Emilio Rayón
- Institut de Tecnologia de Materials, Universitat Politècnica de València (UPV), Camino de Vera, s/n, Código Postal 46022 Valencia, Spain
| | - María José Galotto
- Packaging Innovation Center (LABEN), Department of Food Science and Technology, Faculty of Technology, Center for the Development of Nanoscience and Nanotechnology (CEDENNA), University of Santiago de Chile (USACH), Santiago 9170201, Chile.
| |
Collapse
|
6
|
Rodilla E, Adell M, Baixauli V, Bellver O, Castillo L, Centelles S, Hernández R, Martínez S, Perseguer Z, Prats R, Ruiz D, Salar L, Climent M. Value of estimating pulse wave velocity compared to SCORE in cardiovascular risk stratification in community pharmacies. Med Clin (Barc) 2023; 161:463-469. [PMID: 37735046 DOI: 10.1016/j.medcli.2023.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 06/02/2023] [Accepted: 06/04/2023] [Indexed: 09/23/2023]
Abstract
OBJECTIVES Arterial stiffness is considered to be an intermediate marker with independent prognostic value. The objective of this study is to assess whether the estimation of arterial stiffness can improve CV risk stratification compared to SCORE in patients at community pharmacies. METHODS Observational prospective epidemiological study in which consecutive individuals entering a participating Community Pharmacy are offered a voluntary measurement of blood pressure and estimation of pulse wave velocity by oscillometry (AGEDIO, IEM®) to stratify their CV risk according to SCORE compared to the use of arterial stiffness. RESULTS After nine months of recruitment, data from 923 patients (570 women, 353 men) were collected. 16/122 (13.1%) patients under 40 years and 72/364 (19.8%) over 65 years of age presented pathological stiffness and could be classified as high-risk, even though being out of the age-range of SCORE. Of the 437 (47.3%) patients who were susceptible to calculating SCORE, 42/437 patients (9.6%) presented pathological arterial stiffness. Cholesterol values were available in 281 patients (64.3%). Among them, according to SCORE, only 6 (2.1%) fell into the high-risk category. CONCLUSIONS More than half of the subjects who randomly enter a community pharmacy had ages that make it impossible to calculate the CV risk by SCORE. Among them, arterial damage was detected in 18.1%. Of the other half, 9.6% presented arterial damage and, therefore, high CV risk, when SCORE only detected it in 2.1%. Therefore, estimating arterial stiffness in community pharmacies markedly improves detection of high CV risk compared to SCORE.
Collapse
Affiliation(s)
- Enrique Rodilla
- Internal Medicine Department, Hypertension and Vascular Risk Unit, Hospital Universitario de Sagunto, Sagunto, Spain; Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
| | - Manuel Adell
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Vicente Baixauli
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Otón Bellver
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Lidón Castillo
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Santiago Centelles
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Rosario Hernández
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Sara Martínez
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Zeneida Perseguer
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Rosa Prats
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Desiré Ruiz
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Luis Salar
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| | - Maite Climent
- Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Comunidad Valenciana, SEFAC-CV, Spain
| |
Collapse
|
7
|
Jurado P, Uruén C, Martínez S, Lain E, Sánchez S, Rezusta A, López V, Arenas J. Essential oils of Pinus sylvestris, Citrus limon and Origanum vulgare exhibit high bactericidal and anti-biofilm activities against Neisseria gonorrhoeae and Streptococcus suis. Biomed Pharmacother 2023; 168:115703. [PMID: 37857249 DOI: 10.1016/j.biopha.2023.115703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 10/03/2023] [Accepted: 10/10/2023] [Indexed: 10/21/2023] Open
Abstract
Antimicrobial resistance is a worldwide problem that urges novel alternatives to treat infections. In attempts to find novel molecules, we assess the antimicrobial potential of seven essential oils (EO) of different plants (Pinus sylvestris, Citrus limon, Origanum vulgare, Cymbopogon martini, Cinnamomum cassia, Melaleuca alternifolia and Eucalyptus globulus) against two multidrug-resistant bacteria species, i.e. Neisseria gonorrhoeae and Streptococcus suis. EOs of P. sylvestris and C. limon revealed higher bactericidal activity (MIC ≤ 0.5 mg/mL) and capacity to rapidly disperse biofilms of several N. gonorrhoeae clinical isolates than other EOs. Examination of biofilms exposed to both EO by electron microscopy revealed a reduction of bacterial aggregates, high production of extracellular vesicles, and alteration of cell integrity. This activity was dose-dependent and was enhanced in DNase I-treated biofilms. Antibiotic susceptibility studies confirmed that both EOs affected the outer membrane permeability, and analysis of EO- susceptibility of an LPS-deficient mutant suggested that both EO target the LPS bilayer. Further analysis revealed that α- and β-pinene and d-limonene, components of both EO, contribute to such activity. EO of C. martini, C. cassia, and O. vulgare exhibited promising antimicrobial activity (MIC ≤ 0.5 mg/mL) against S. suis, but only EO of O. vulgare exhibited a high biofilm dispersal activity, which was also confirmed by electron microscopy studies. To conclude, the EO of P. sylvestris, C. limon and O. vulgare studied in this work exhibit bactericidal and anti-biofilm activities against gonococcus and streptococcus, respectively.
Collapse
Affiliation(s)
- Paula Jurado
- Unit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain; Instituto Agroalimentario de Aragón, IA2, Universidad de Zaragoza-CITA, IIS Aragón, 50059 Zaragoza, Spain
| | - Cristina Uruén
- Unit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain; Instituto Agroalimentario de Aragón, IA2, Universidad de Zaragoza-CITA, IIS Aragón, 50059 Zaragoza, Spain
| | - Sara Martínez
- Unit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain
| | - Elena Lain
- Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - Sandra Sánchez
- Departament of Microbiology y Parasitology, University of Santiago de Compostela, Santiago de Compostela, Spain
| | | | - Víctor López
- Instituto Agroalimentario de Aragón, IA2, Universidad de Zaragoza-CITA, IIS Aragón, 50059 Zaragoza, Spain; Department of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, 50830 Villanueva de Gállego (Zaragoza), Spain
| | - Jesús Arenas
- Unit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain; Instituto Agroalimentario de Aragón, IA2, Universidad de Zaragoza-CITA, IIS Aragón, 50059 Zaragoza, Spain.
| |
Collapse
|
8
|
Piédrola I, Martínez S, Gradillas A, Villaseñor A, Alonso-Herranz V, Sánchez-Vera I, Escudero E, Martín-Antoniano IA, Varona JF, Ruiz A, Castellano JM, Muñoz Ú, Sádaba MC. Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients. Front Immunol 2023; 14:1188786. [PMID: 37426663 PMCID: PMC10327431 DOI: 10.3389/fimmu.2023.1188786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Accepted: 05/26/2023] [Indexed: 07/11/2023] Open
Abstract
Background Antibodies to lipids are part of the first line of defense against microorganisms and regulate the pro/anti-inflammatory balance. Viruses modulate cellular lipid metabolism to enhance their replication, and some of these metabolites are proinflammatory. We hypothesized that antibodies to lipids would play a main role of in the defense against SARS-CoV-2 and thus, they would also avoid the hyperinflammation, a main problem in severe condition patients. Methods Serum samples from COVID-19 patients with mild and severe course, and control group were included. IgG and IgM to different glycerophospholipids and sphingolipids were analyzed using a high-sensitive ELISA developed in our laboratory. A lipidomic approach for studying lipid metabolism was performed using ultra-high performance liquid chromatography coupled to electrospray ionization and quadrupole time-of-flight mass spectrometry (UHPLC-ESI-QTOF-MS). Results Mild and severe COVID-19 patients had higher levels of IgM to glycerophosphocholines than control group. Mild COVID-19 patients showed higher levels of IgM to glycerophosphoinositol, glycerophosphoserine and sulfatides than control group and mild cases. 82.5% of mild COVID-19 patients showed IgM to glycerophosphoinositol or glycerophosphocholines plus sulfatides or glycerophosphoserines. Only 35% of severe cases and 27.5% of control group were positive for IgM to these lipids. Lipidomic analysis identify a total of 196 lipids, including 172 glycerophospholipids and 24 sphingomyelins. Increased levels of lipid subclasses belonging to lysoglycerophospholipids, ether and/or vinyl-ether-linked glycerophospholipids, and sphingomyelins were observed in severe COVID-19 patients, when compared with those of mild cases and control group. Conclusion Antibodies to lipids are essential for defense against SARS-CoV-2. Patients with low levels of anti-lipid antibodies have an elevated inflammatory response mediated by lysoglycerophospholipids. These findings provide novel prognostic biomarkers and therapeutic targets.
Collapse
Affiliation(s)
- Ignacio Piédrola
- Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Sara Martínez
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Ana Gradillas
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Alma Villaseñor
- Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Vanesa Alonso-Herranz
- Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Isabel Sánchez-Vera
- Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Esther Escudero
- Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - Isabel A. Martín-Antoniano
- Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
- Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - Jose Felipe Varona
- Servicio de Medicina Interna, Hospital Universitario Hospitales de Madrid (HM), Boadilla del Monte, Madrid, Spain
| | - Andrés Ruiz
- Servicio de Medicina Interna, Hospital Universitario Hospitales de Madrid (HM), Boadilla del Monte, Madrid, Spain
| | - Jose María Castellano
- Servicio de Medicina Interna, Hospital Universitario Hospitales de Madrid (HM), Boadilla del Monte, Madrid, Spain
| | - Úrsula Muñoz
- Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| | - María C. Sádaba
- Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Madrid, Spain
| |
Collapse
|
9
|
Villegas C, Martínez S, Torres A, Rojas A, Araya R, Guarda A, Galotto MJ. Processing, Characterization and Disintegration Properties of Biopolymers Based on Mater-Bi ® and Ellagic Acid/Chitosan Coating. Polymers (Basel) 2023; 15:polym15061548. [PMID: 36987328 PMCID: PMC10053201 DOI: 10.3390/polym15061548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Revised: 03/16/2023] [Accepted: 03/17/2023] [Indexed: 03/30/2023] Open
Abstract
Among the most promising synthetic biopolymers to replace conventional plastics in numerous applications is MaterBi® (MB), a commercial biodegradable polymer based on modified starch and synthetic polymers. Actually, MB has important commercial applications as it shows interesting mechanical properties, thermal stability, processability and biodegradability. On the other hand, research has also focused on the incorporation of natural, efficient and low-cost active compounds into various materials with the aim of incorporating antimicrobial and/or antioxidant capacities into matrix polymers to extend the shelf life of foods. Among these is ellagic acid (EA), a polyphenolic compound abundant in some fruits, nuts and seeds, but also in agroforestry and industrial residues, which seems to be a promising biomolecule with interesting biological activities, including antioxidant activity, antibacterial activity and UV-barrier properties. The objective of this research is to develop a film based on commercial biopolymer Mater-Bi® (MB) EF51L, incorporating active coating from chitosan with a natural active compound (EA) at two concentrations (2.5 and 5 wt.%). The formulations obtained complete characterization and were carried out in order to evaluate whether the incorporation of the coating significantly affects thermal, mechanical, structural, water-vapor barrier and disintegration properties. From the results, FTIR analysis yielded identification, through characteristic peaks, that the type of MB used is constituted by three polymers, namely PLA, TPS and PBAT. With respect to the mechanical properties, the values of tensile modulus and tensile strength of the MB-CHI film were between 15 and 23% lower than the values obtained for the MB film. The addition of 2.5 wt.% EA to the CHI layer did not generate changes in the mechanical properties of the system, whereas a 5 wt.% increase in ellagic acid improved the mechanical properties of the CHI film through the addition of natural phenolic compounds at high concentrations. Finally, the disintegration process was mainly affected by the PBAT biopolymer, causing the material to not disintegrate within the times indicated by ISO 20200.
Collapse
Affiliation(s)
- Carolina Villegas
- Center for Packaging Innovation (LABEN), Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Technology Faculty, University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - Sara Martínez
- Center for Packaging Innovation (LABEN), Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Technology Faculty, University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - Alejandra Torres
- Center for Packaging Innovation (LABEN), Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Technology Faculty, University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - Adrián Rojas
- Center for Packaging Innovation (LABEN), Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Technology Faculty, University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - Rocío Araya
- Center for Packaging Innovation (LABEN), Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Technology Faculty, University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - Abel Guarda
- Center for Packaging Innovation (LABEN), Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Technology Faculty, University of Santiago de Chile (USACH), Santiago 9170201, Chile
| | - María José Galotto
- Center for Packaging Innovation (LABEN), Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Technology Faculty, University of Santiago de Chile (USACH), Santiago 9170201, Chile
| |
Collapse
|
10
|
Mateos MV, Prosper F, Martin Sánchez J, Ocio EM, Oriol A, Motlló C, Michot JM, Jarque I, Iglesias R, Solé M, Martínez S, Kahatt C, Fudio S, Corral G, Zeaiter A, Montilla L, Ribrag V. Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. Cancer Med 2023; 12:3999-4009. [PMID: 36127823 PMCID: PMC9972151 DOI: 10.1002/cam4.5250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Revised: 06/23/2022] [Accepted: 08/02/2022] [Indexed: 11/10/2022] Open
Abstract
Previous studies showed antitumor activity for plitidepsin plus dexamethasone (DXM) in relapsed/refractory multiple myeloma (r/r MM), and in vitro synergism with bortezomib (BTZ) or DXM against MM cells. This phase I trial evaluated plitidepsin (3-h intravenous infusion Day 1 and 15), BTZ (subcutaneous bolus Day 1, 4, 8, and 11), and DXM (orally Day 1, 8, 15, and 22), every 4 weeks in 36 r/r MM patients. Twenty-two patients were treated using a standard dose escalation design (10 at the recommended dose [RD] cohort), and 14 additional patients were treated to expand the RD cohort. No dose-limiting toxicities (DLTs) occurred during dose escalation. The highest dose level evaluated (plitidepsin 5.0 mg/m2 , BTZ 1.3 mg/m2 , DXM 40.0 mg) was the RD for phase II studies. Results shown herein are focused on this RD. Two patients had DLTs (grade 3 diarrhea, and grade 3 nausea/vomiting refractory to antiemetic therapy). Grade ≥ 3 hematological toxicity (thrombocytopenia 46%, anemia 33%, and neutropenia 17%) was manageable and did not result in treatment discontinuation. Transient and manageable grade 3 ALT increase (26%) was the most common biochemical abnormality. At the RD cohort, overall response rate was 22.2% (95%CI, 6.4%-47.6%), including one stringent complete response, one very good partial response, and two partial responses in r/r patients to BTZ and/or lenalidomide. The clinical benefit rate was 77.8% (95%CI, 52.4-93.6%). No major pharmacokinetic drug-drug interaction was found. In conclusion, the triple combination of plitidepsin, BTZ, and DXM showed an acceptable safety profile and had moderate activity in adult patients with r/r MM.
Collapse
Affiliation(s)
| | - Felipe Prosper
- Clínica Universidad de Navarra, Pamplona, Spain.,Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain
| | | | - Enrique M Ocio
- Hospital Universitario de Salamanca, Salamanca, Spain.,Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
| | - Albert Oriol
- Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain
| | - Cristina Motlló
- Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain
| | | | | | | | - María Solé
- Hospital Universitario Virgen del Rocio, Sevilla, Spain
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Toribio-Vazquez C, Cansino R, Fernández-Pascual E, Eguibar A, Ayllon H, Solano-Heranz P, Perez-Carral J, Mainez J, Giron M, Rodriguez A, Yebes A, Alonso M, Martínez S, Martínez-Piñeiro L. Comparing the use of AquaBeam® and HoLEP for the treatment of patients with benign prostatic hyperplasia. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01165-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
12
|
Soler E, Marín E, Guerrero I, Martínez S, Fernández MA, Valero C. Elizabethkingia miricola: an opportunistic pathogen in ICU. Eur J Public Health 2022. [DOI: 10.1093/eurpub/ckac131.406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The Elizabethkingia genus is formed by a group of bacteria which are widely distributed in nature. Elizabethkingia is not part of human microbiota, therefore is considered to be an opportunistic pathogen. In the last years, it has become a cause of potentially fatal disease, becoming an emerging bacteria of increasing relevance. The objective of this study is to describe the impact of Elizabethkingia bacteria in infected patients in the ICU of a hospital in Granada.
Methods
Descriptive study. Patients who have been isolated in a biological sample of Elizabethkingia miricola throughout the year 2.021 in the ICU of San Cecilio University Hospital in Granada. Date and place of isolation were registered. Other variables registered were sex, age, length of ICU stay, days between ICU admission and bacterium isolation, days between bacterium isolation and death, infection, cause of admission or cause of death.
Results
Bacterium was isolated in 15 patients. Cause of admission was COVID-19 in 73.3% of patients. 73.3% were men and 26.6% women.The average age was 56.9 years. The average length of ICU stay was 43.8 days. 4 patients were diagnosed with ventilator-associated pneumonia and 5 patients were diagnosed with tracheobronchitis.The average days between ICU admission and bacterium isolation was 26,4 days. The average days between mechanical ventilation and bacterium isolation was 25.9 days. 53.3% of patients died. The average days between bacteria isolation and death was 18.2 days.
Conclusions
Elizabethkingia miricola is an emerging bacterium under special vigilance due to its capacity to cause major morbidity and mortality in admitted patients in ICU. The rapid identification and the study of the antibiotic susceptibility is considered of special relevance so they can be correctly managed to avoid infections and complications resulting from this microorganism.
Key messages
• Elizabethkingia is a special surveillance bacterie due to its morbidity and mortality effects.
• Elizabethkingia could be a severity indicator in admitted patients to the ICU.
Collapse
Affiliation(s)
- E Soler
- Medicina Preventiva y Salud Pública, Hospital Clínico San Cecilio , Granada, Spain
| | - E Marín
- Medicina Preventiva y Salud Pública, Hospital Clínico San Cecilio , Granada, Spain
| | - I Guerrero
- Medicina Preventiva y Salud Pública, Hospital Clínico San Cecilio , Granada, Spain
| | - S Martínez
- Medicina Preventiva y Salud Pública, Hospital Clínico San Cecilio , Granada, Spain
| | - MA Fernández
- Medicina Preventiva y Salud Pública, Hospital Clínico San Cecilio , Granada, Spain
| | - C Valero
- Medicina Preventiva y Salud Pública, Hospital Clínico San Cecilio , Granada, Spain
| |
Collapse
|
13
|
Martínez S, Espert M, Salvador A, Sanz T. The role of oil concentration on the rheological properties, microstructure, and in vitro digestion of cellulose ether emulsions. Food Hydrocoll 2022. [DOI: 10.1016/j.foodhyd.2022.107793] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
14
|
Mínguez A, Ladrón P, Martínez S, Del Val A, Nos P, de-Madaria E. Predictive model of persistent choledocholithiasis in patients with acute biliary pancreatitis. Gastroenterología y Hepatología 2022; 46:297-304. [PMID: 36243251 DOI: 10.1016/j.gastrohep.2022.10.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 09/06/2022] [Accepted: 10/05/2022] [Indexed: 11/06/2022]
Abstract
BACKGROUND Choledocholithiasis causing acute biliary pancreatitis (ABP) may migrate to the duodenum or persist in the common bile duct (CBD). We developed a model for predicting persistent choledocholithiasis (PC) in patients with ABP. METHODS This retrospective cohort study included 204 patients, age ≥18 years (mean age: 73 years, 65.7% women), admitted for ABP in 2013-2018, with at least a magnetic resonance cholangiopancreatography (MRCP), endoscopic ultrasonography (EUS), and/or endoscopic retrograde cholangiopancreatography (ERCP). Epidemiological, analytical, imaging, and endoscopic variables were compared between patients with and without PC. Multivariate logistic regression analyses were performed to develop a predictive model of PC. RESULTS Patients underwent MRCP (n=145, 71.1), MRCP and ERCP (n=44, 21.56%), EUS and ERCP (n=1, 0.49%), or ERCP (n=14, 6.86%). PC was detected in 49 patients (24%). PC was strongly associated with CBD dilation, detected in the emergency ultrasound (p<0.001; OR=27; 95% CI: 5.8-185.5), increased blood levels of gamma glutamyl transpeptidase, detected at 72h (p=0.008; OR=3.4; 95% CI: 1.5-8.9); and biliary sludge in the gallbladder (p=0.008; OR=0.03; 95% CI: 0.001-0.3). CONCLUSIONS The predictive model showed a validated area under the curve (AUC) of 0.858 for detecting PC in patients with ABP. A nomogram was developed based on model results. CONCLUSIONS The predictive model was highly effective in detecting PC in patients with ABP. Therefore, this model could be useful in clinical practice.
Collapse
|
15
|
Lasa EM, Herrero L, Martínez S, Arruti N, Oliver P, Joral A. Use of concentrated plasma-derived subcutaneous C1 inhibitor as long-term prophylaxis in an 8-year-old child with hereditary angioedema. J Investig Allergol Clin Immunol 2022:0. [PMID: 36000819 DOI: 10.18176/jiaci.0855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- E M Lasa
- Hospital Universitario de Donostia. San Sebastián, España
| | - L Herrero
- Hospital de Mendaro. Mendaro, España
| | - S Martínez
- Hospital Universitario de Donostia. San Sebastián, España
| | - N Arruti
- Hospital Universitario de Donostia. San Sebastián, España
| | - P Oliver
- Hospital de Mendaro. Mendaro, España
| | - A Joral
- Hospital Universitario de Donostia. San Sebastián, España
| |
Collapse
|
16
|
Carol M, Pérez-Guasch M, Solà E, Cervera M, Martínez S, Juanola A, Ma AT, Avitabile E, Napoleone L, Pose E, Graupera I, Honrubia M, Korenjak M, Torres F, Ginès P, Fabrellas N. Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life. PLoS One 2022; 17:e0265153. [PMID: 35385510 PMCID: PMC8986095 DOI: 10.1371/journal.pone.0265153] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Accepted: 02/24/2022] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND AND AIMS Stigmatization is a well-documented problem of some diseases. Perceived stigma is common in alcohol-related liver disease and hepatitis C, but little information exists on stigma in patients with non-alcoholic fatty liver disease (NAFLD). Aim of the study was to investigate frequency and characteristics of perceived stigma among patients with NAFLD. METHODS One-hundred and ninety-seven patients seen at the liver clinic were included: a study group of 144 patients with NAFLD, 50 with cirrhosis (34 compensated, 16 decompensated), and a control group of 53 patients with alcohol-related cirrhosis. Demographic, clinical, and laboratory data were collected. Quality-of-life was assessed by chronic liver disease questionnaire (CLDQ). Perceived stigma was assessed using a specific questionnaire for patients with liver diseases categorized in 4 domains: stereotypes, discrimination, shame, and social isolation. RESULTS Perceived stigma was common in patients with NAFLD (99 patients, 69%) and affected all 4 domains assessed. The frequency was slightly higher, yet not significant, in patients with NAFLD cirrhosis vs those without (72% vs 67%, respectively; p = 0.576). In patients without cirrhosis perceived stigma was unrelated to stage of disease, since frequency was similar in patients with no or mild fibrosis compared to those with moderate/severe fibrosis (66% vs 68%, respectively). There were no differences in perceived stigma between patients with compensated cirrhosis and these with decompensated cirrhosis. Among patients with cirrhosis, stigmatization was more common in alcohol-related vs NAFLD-cirrhosis, yet differences were only significant in two domains. In patients with NAFLD, perceived stigma correlated with poor quality-of-life, but not with demographic or clinical variables. CONCLUSIONS Perceived stigmatization is common among patients with NAFLD independently of disease stage, is associated with impaired quality-of-life, and may be responsible for stereotypes, discrimination, shame, and social isolation, which may affect human and social rights of affected patients.
Collapse
Affiliation(s)
- Marta Carol
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain.,School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain
| | - Martina Pérez-Guasch
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Elsa Solà
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain.,School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain
| | - Marta Cervera
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain.,School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain
| | - Sara Martínez
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Adrià Juanola
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Ann T Ma
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Emma Avitabile
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Laura Napoleone
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Elisa Pose
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Isabel Graupera
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain
| | - Maria Honrubia
- School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain
| | - Marko Korenjak
- European Liver Patients Association (ELPA), Brussels, Belgium
| | - Ferran Torres
- Medical Statistics Core Facility, Institut d'Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Catalonia, Spain.,Biostatistics Unit, Faculty of Medicine, Universitat Autónoma de Barcelona, Barcelona, Catalonia, Spain
| | - Pere Ginès
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain.,School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain
| | - Núria Fabrellas
- Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Catalonia, Spain.,School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain
| | | |
Collapse
|
17
|
Cobas N, Gómez-Limia L, Franco I, Martínez S. Amino acid profile and protein quality related to canning and storage of swordfish packed in different filling media. J Food Compost Anal 2022. [DOI: 10.1016/j.jfca.2021.104328] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
18
|
Domínguez-Sala E, Valdés-Sánchez L, Canals S, Reiner O, Pombero A, García-López R, Estirado A, Pastor D, Geijo-Barrientos E, Martínez S. Abnormalities in Cortical GABAergic Interneurons of the Primary Motor Cortex Caused by Lis1 (Pafah1b1) Mutation Produce a Non-drastic Functional Phenotype. Front Cell Dev Biol 2022; 10:769853. [PMID: 35309904 PMCID: PMC8924048 DOI: 10.3389/fcell.2022.769853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Accepted: 01/31/2022] [Indexed: 11/25/2022] Open
Abstract
LIS1 (PAFAH1B1) plays a major role in the developing cerebral cortex, and haploinsufficient mutations cause human lissencephaly type 1. We have studied morphological and functional properties of the cerebral cortex of mutant mice harboring a deletion in the first exon of the mouse Lis1 (Pafah1b1) gene, which encodes for the LisH domain. The Lis1/sLis1 animals had an overall unaltered cortical structure but showed an abnormal distribution of cortical GABAergic interneurons (those expressing calbindin, calretinin, or parvalbumin), which mainly accumulated in the deep neocortical layers. Interestingly, the study of the oscillatory activity revealed an apparent inability of the cortical circuits to produce correct activity patterns. Moreover, the fast spiking (FS) inhibitory GABAergic interneurons exhibited several abnormalities regarding the size of the action potentials, the threshold for spike firing, the time course of the action potential after-hyperpolarization (AHP), the firing frequency, and the frequency and peak amplitude of spontaneous excitatory postsynaptic currents (sEPSC’s). These morphological and functional alterations in the cortical inhibitory system characterize the Lis1/sLis1 mouse as a model of mild lissencephaly, showing a phenotype less drastic than the typical phenotype attributed to classical lissencephaly. Therefore, the results described in the present manuscript corroborate the idea that mutations in some regions of the Lis1 gene can produce phenotypes more similar to those typically described in schizophrenic and autistic patients and animal models.
Collapse
Affiliation(s)
- E Domínguez-Sala
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - L Valdés-Sánchez
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - S Canals
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - O Reiner
- Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
| | - A Pombero
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - R García-López
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - A Estirado
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - D Pastor
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - E Geijo-Barrientos
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain
| | - S Martínez
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain.,Centro de Investigación Biomédica en Red en Salud Mental CIBERSAM, Madrid, Spain
| |
Collapse
|
19
|
Domínguez-Sala E, Andreu-Cervera A, Martín-Climent P, Murcia-Ramón R, Martínez S, Geijo-Barrientos E. Properties of the epileptiform activity in the cingulate cortex of a mouse model of LIS1 dysfunction. Brain Struct Funct 2022; 227:1599-1614. [PMID: 35103859 PMCID: PMC9098610 DOI: 10.1007/s00429-022-02458-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Accepted: 01/09/2022] [Indexed: 11/02/2022]
Abstract
Dysfunction of the LIS1 gene causes lissencephaly, a drastic neurological disorder characterized by a deep disruption of the cortical structure. We aim to uncover alterations of the cortical neuronal networks related with the propagation of epileptiform activity in the Lis1/sLis1 mouse, a model lacking the LisH domain in heterozygosis. We did extracellular field-potential and intracellular recordings in brain slices of the anterior cingulate cortex (ACC) or the retrosplenial cortex (RSC) to study epileptiform activity evoked in the presence of bicuculline (10 µM), a blocker of GABAA receptors. The sensitivity to bicuculline of the generation of epileptiform discharges was similar in wild type (WT) and Lis1/sLis1 cortex (EC50 1.99 and 2.24 µM, respectively). In the Lis1/sLis1 cortex, we observed a decreased frequency of the oscillatory post-discharges of the epileptiform events; also, the propagation of epileptiform events along layer 2/3 was slower in the Lis1/sLis1 cortex (WT 47.69 ± 2.16 mm/s, n = 25; Lis1/sLis1 37.34 ± 2.43 mm/s, n = 15; p = 0.004). The intrinsic electrophysiological properties of layer 2/3 pyramidal neurons were similar in WT and Lis1/sLis1 cortex, but the frequency of the spontaneous EPSCs was lower and their peak amplitude higher in Lis1/sLis1 pyramidal neurons. Finally, the propagation of epileptiform activity was differently affected by AMPA receptor blockers: CNQX had a larger effect in both ACC and RSC while GYKI53655 had a larger effect only in the ACC in the WT and Lis1/sLis1 cortex. All these changes indicate that the dysfunction of the LIS1 gene causes abnormalities in the properties of epileptiform discharges and in their propagation along the layer 2/3 in the anterior cingulate cortex and in the restrosplenial cortex.
Collapse
Affiliation(s)
- E Domínguez-Sala
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Campus de San Juan, C/Ramón y Cajal sn, San Juan de Alicante, 03550, Alicante, Spain.
| | - A Andreu-Cervera
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Campus de San Juan, C/Ramón y Cajal sn, San Juan de Alicante, 03550, Alicante, Spain
| | - P Martín-Climent
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Campus de San Juan, C/Ramón y Cajal sn, San Juan de Alicante, 03550, Alicante, Spain
| | - R Murcia-Ramón
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Campus de San Juan, C/Ramón y Cajal sn, San Juan de Alicante, 03550, Alicante, Spain
| | - S Martínez
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Campus de San Juan, C/Ramón y Cajal sn, San Juan de Alicante, 03550, Alicante, Spain.,Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM, Spain), Madrid, Spain
| | - Emilio Geijo-Barrientos
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Campus de San Juan, C/Ramón y Cajal sn, San Juan de Alicante, 03550, Alicante, Spain.
| |
Collapse
|
20
|
Pastor D, Valera H, Olmo JA, Estirado A, Martínez S. Shock wave and mesenchymal stem cells as treatment in the acute phase of spinal cord injury: A pilot study. Rehabilitacion (Madr) 2022; 56:1-10. [PMID: 33966896 DOI: 10.1016/j.rh.2021.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2020] [Revised: 03/19/2021] [Accepted: 03/23/2021] [Indexed: 06/12/2023]
Abstract
INTRODUCTION Spinal cord injury (SCI) is a complex pathology with thousands of patients worldwide. During the acute early phase, neural tissue shows some regenerative properties that disappear at the chronic phase. Shock Waves and Stem Cells have been proposed as a possible therapy. METHODS Here, we analyse Shock Waves' immediate effect over spinal cord genetic response in the injured and healthy spinal cord and the effect of Shock Waves and combined Shock Waves plus Stem Cells distally grafted to treat the first month after spinal cord injury. RESULTS The immediate application of shock waves increases VEGF (Vascular Endothelial Growth Factor) but reduces the BDNF (Brain-Derived Growth Factor) RNA (Ribonucleic acid) response. Shock wave therapy increases GFAP (Glial fibrillary acidic protein) positive cells and vascularity during the treatment's acute phase. CONCLUSION Shock wave treatment seems to be enough to produce benefits in the acute phase of spinal cord injury, with no accumulative positive effects when mesenchymal stem cell graft is applied together.
Collapse
Affiliation(s)
- D Pastor
- Department of Sports Science, Sports Research Centre, University Miguel Hernández of Elche, Elche, Spain.
| | - H Valera
- Servicio de Rehabilitación, University Hospital Virgen de la Arrixaca, Murcia, Spain
| | - J A Olmo
- Servicio de Rehabilitación, University Hospital Virgen de la Arrixaca, Murcia, Spain
| | - A Estirado
- Instituto de Neurociencias de Alicante, Universidad Miguel Hernández de Elche - Centro Superior de Investigaciones Científicas, Spain
| | - S Martínez
- Instituto de Neurociencias de Alicante, Universidad Miguel Hernández de Elche - Centro Superior de Investigaciones Científicas, Spain
| |
Collapse
|
21
|
Gómez-Limia L, Cobas N, Martínez S. Proximate composition, fatty acid profile and total amino acid contents in samples of the European eel (Anguilla anguilla) of different weights. Int J Gastron Food Sci 2021. [DOI: 10.1016/j.ijgfs.2021.100364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
22
|
Cobas N, Piñeiro-Lago L, Gómez-Limia L, Franco I, Martínez S. Vitamin retention during the canning of swordfish (Xiphias gladius) with different filling media. J Food Sci 2021; 86:1704-1713. [PMID: 33836097 DOI: 10.1111/1750-3841.15691] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Revised: 01/20/2021] [Accepted: 02/17/2021] [Indexed: 10/21/2022]
Abstract
Swordfish (Xiphias gladius) is an economically and nutritionally important fish. The aims of this study were to determine the effects of the various steps of the canning process and of different filling media (olive oil, corn oil, sunflower oil, and high oleic sunflower oil) on the fat- and water-soluble vitamin contents of swordfish. An HPLC-based method was used for this purpose. The canning process led to loss of some vitamins, particularly of vitamin D3 . Loss of this vitamin mainly occurred during storage and although important (89.34% to 91.36%), canned swordfish can be considered a good source of vitamin D3 , providing between 50% and 64% of the RDI. The frying process also caused significant loss of vitamin B9 (73.7%). However, the vitamin E content increased due to contributions from the frying and filling oils. The canned swordfish packed in olive oil had lower vitamin A (107.35 µg/100 g) and E (1.58 mg/100 g) contents than the fish packed in sunflower oil (193.28 µg/100 g and 2.28 mg/100 g, respectively). The swordfish packed in sunflower oil also had the highest B2 (0.036 mg/100 g) content. The swordfish packed in corn oil had the lowest vitamin A (80.17 µg/100 g) and B2 (0.012 mg/100 g) contents, while the samples packed in high oleic sunflower oil had the lowest contents of vitamins B9 (0.14 µg/100 g) and B12 (2.37 mg/100 g). PRACTICAL APPLICATION: Swordfish (Xiphias gladius) is consumed worldwide and is economically very important in the seafood industry. The canning process caused losses of some vitamins, particularly of vitamins D3 and B9 ; however, the vitamin E content increased due to the frying and filling oils. The study findings may contribute to increasing knowledge about how processing, storage and the filling medium influence the composition of canned fish.
Collapse
Affiliation(s)
- N Cobas
- Área de Tecnología de los Alimentos, Universidad de Vigo, Facultad de Ciencias, Campus de Ourense, Ourense, 32004, Spain
| | - L Piñeiro-Lago
- Área de Tecnología de los Alimentos, Universidad de Vigo, Facultad de Ciencias, Campus de Ourense, Ourense, 32004, Spain
| | - L Gómez-Limia
- Área de Tecnología de los Alimentos, Universidad de Vigo, Facultad de Ciencias, Campus de Ourense, Ourense, 32004, Spain
| | - I Franco
- Área de Tecnología de los Alimentos, Universidad de Vigo, Facultad de Ciencias, Campus de Ourense, Ourense, 32004, Spain
| | - S Martínez
- Área de Tecnología de los Alimentos, Universidad de Vigo, Facultad de Ciencias, Campus de Ourense, Ourense, 32004, Spain
| |
Collapse
|
23
|
Alberti F, Baake E, Letter I, Martínez S. Solving the migration-recombination equation from a genealogical point of view. J Math Biol 2021; 82:41. [PMID: 33774735 PMCID: PMC8004498 DOI: 10.1007/s00285-021-01584-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2020] [Revised: 10/08/2020] [Accepted: 02/14/2021] [Indexed: 11/29/2022]
Abstract
We consider the discrete-time migration–recombination equation, a deterministic, nonlinear dynamical system that describes the evolution of the genetic type distribution of a population evolving under migration and recombination in a law of large numbers setting. We relate this dynamics (forward in time) to a Markov chain, namely a labelled partitioning process, backward in time. This way, we obtain a stochastic representation of the solution of the migration–recombination equation. As a consequence, one obtains an explicit solution of the nonlinear dynamics, simply in terms of powers of the transition matrix of the Markov chain. The limiting and quasi-limiting behaviour of the Markov chain are investigated, which gives immediate access to the asymptotic behaviour of the dynamical system. We finally sketch the analogous situation in continuous time.
Collapse
Affiliation(s)
- F Alberti
- Faculty of Mathematics, Bielefeld University, Postbox 100131, 33501, Bielefeld, Germany
| | - E Baake
- Faculty of Mathematics, Bielefeld University, Postbox 100131, 33501, Bielefeld, Germany.
| | - I Letter
- Statistics Department, University of Oxford, 24-29 St Giles, Oxford, OX1 3LB, UK
| | - S Martínez
- Department of Mathematical Engineering and Center of Mathematical Modeling, UMI 2807 UCHILE-CNRS, Universidad de Chile, Santiago, Chile
| |
Collapse
|
24
|
Ruiz Wills C, Tassani S, Di Gregorio S, Martínez S, González Ballester MA, Humbert L, Noailly J, Río LMD. Fragilidad relativa de fémures osteoporóticos evaluados con DXA y simulación de caídas con elementos finitos guiados por radiografías de urgencias. Rev Osteoporos Metab Miner 2020. [DOI: 10.4321/s1889-836x2020000200005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
25
|
Suárez P, Gutiérrez A, Salazar V, Puche M, Serrano Y, Martínez S, González G, Fernández‐Delgado M. Virulence properties and antimicrobial resistance of
Pseudomonas aeruginosa
isolated from cave waters at Roraima Tepui, Guayana Highlands. Lett Appl Microbiol 2020; 70:372-379. [DOI: 10.1111/lam.13283] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Revised: 02/05/2020] [Accepted: 02/06/2020] [Indexed: 12/31/2022]
Affiliation(s)
- P. Suárez
- Departamento de Biología de Organismos Universidad Simón Bolívar (USB) Caracas Venezuela
| | - A.V. Gutiérrez
- Centro de Biofísica y Bioquímica Instituto Venezolano de Investigaciones Científicas (IVIC) Caracas Venezuela
| | - V. Salazar
- Centro de Biofísica y Bioquímica Instituto Venezolano de Investigaciones Científicas (IVIC) Caracas Venezuela
| | - M.L. Puche
- Centro de Ingeniería de Materiales y Nanotecnología (CIMN) IVIC Caracas Venezuela
| | - Y. Serrano
- Departamento de Biología de Organismos Universidad Simón Bolívar (USB) Caracas Venezuela
| | - S. Martínez
- Departamento de Biología de Organismos Universidad Simón Bolívar (USB) Caracas Venezuela
| | - G. González
- Centro de Ingeniería de Materiales y Nanotecnología (CIMN) IVIC Caracas Venezuela
- Escuela de Ciencias Físicas y Nanotecnología Yachay Tech Urcuquí Ecuador
| | - M. Fernández‐Delgado
- Centro de Biofísica y Bioquímica Instituto Venezolano de Investigaciones Científicas (IVIC) Caracas Venezuela
| |
Collapse
|
26
|
Hernando-Calvo A, Mirallas O, Marmolejo D, Felip E, Javierre GV, Garralda E, Gutierrez R, Feliu B, Martínez S, Dienstmann R, Braña I. Clinical biomarkers as predictors of immunotherapy (IT) benefit in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pt). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz449.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Hernando-Calvo A, Mirallas O, Marmolejo D, Felip E, Garralda E, Javierre GV, Feliu B, Martínez S, Gutierrez R, Dienstmann R, Braña I. Efficacy of Cetuximab Based Chemotherapy after Immunotherapy Treatments (IT) in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Patients (pts). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz450.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
28
|
García E, Alpízar A, Fajardo R, Córdova D, Pérez L, Martínez S. Epidemiology of tumors in dogs in the capital of the state of Mexico from 2002-2016. ARQ BRAS MED VET ZOO 2019. [DOI: 10.1590/1678-4162-10534] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
ABSTRACT A retrospective and cross-sectional study of canine tumors was performed in the capital of State of Mexico from 2002-2016. Since then, 393 tumors were remitted. Descriptive epidemiology was made from all data: breed, age, sex, and tumor features. Then the risk association between cutaneous and non-cutaneous tumors with variables such as sex, breed, and age were analyzed through an exact Fisher test and Odds ratio. In addition, some characteristics of the canine population were studied under a survey. Of all tumors, skin tumors were the most frequent (59.0%). The group of tumors related to ultraviolet radiation was the most common (15.1%). The frequency of tumors in females was 53%, nevertheless, males had more risk to develop cutaneous tumors (OR=1.88, 1.24-2.84) (0.003). The Pure breeds were the most common (82.5%) and the most frequent age range was > 7 years (54.7%). The survey showed that males (53%) and the age range 1-7 years (62.1%) were the most frequent. Conclusions, age, breed, and sex were identified as the major risk factors for tumorigenesis. Likewise, skin tumors were associated with exposure to ultraviolet radiation, probably to the height of the locality (2667mamls).
Collapse
Affiliation(s)
- E. García
- Universidad Autónoma del Estado de México, Mexico
| | - A. Alpízar
- Universidad Autónoma del Estado de México, Mexico
| | - R. Fajardo
- Universidad Autónoma del Estado de México, Mexico
| | - D. Córdova
- Instituto Nacional de Investigaciones Forestales Agrícolas y Pecuarias˗, Mexico
| | - L. Pérez
- Universidad Autónoma del Estado de México, Mexico
| | - S. Martínez
- Universidad Autónoma del Estado de México, Mexico
| |
Collapse
|
29
|
Moraña MN, Sevillano C, Martínez S, Carral ML. Giant cell arteritis and usefulness of a predictive calculator. ACTA ACUST UNITED AC 2019; 94:426-429. [PMID: 31147092 DOI: 10.1016/j.oftal.2019.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Revised: 04/10/2019] [Accepted: 04/13/2019] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Giant cell arteritis (GCA) is an inflammatory disease with serious visual sequelae, in which the diagnosis with the temporal artery biopsy (TAB) is very important. MATERIAL AND METHODS All cases of GCA were collected from 2010 to 2016 (60) in a retrospective study with temporal artery biopsy performed. The vision aspects of these patients were also analysed, along with the need / predictability of the biopsy. RESULTS The average incidence of GCA was 34.3 cases per 100,000 inhabitants/year in those older than 50 years. The mean age was 79.9 with a predilection for females (1.9: 1). TAB was requested in 100% of cases, with 18.3% with positive results. The AAR criteria and / or TAB calculator could have avoided most (90%) of the biopsies. CONCLUSIONS In the present study, the mean incidence of GCA was 34.3 cases per 100,000 inhabitants/year older than 50 years. The predictability calculator described by González-López is useful in this environment for decision making on the diagnosis of GCA and the indication of a TAB, in such a way that it can help to reduce the performing of biopsies only in doubtful cases.
Collapse
Affiliation(s)
- M N Moraña
- Servicio de Oftalmología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España.
| | - C Sevillano
- Servicio de Oftalmología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España
| | - S Martínez
- Medicina Familiar y Comunitaria, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España
| | - M L Carral
- Servicio de Cirugía General, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España
| |
Collapse
|
30
|
Aranzabal MA, Arruti N, Joral A, Lasa EM, Martínez S, Echenagusia MA. Contact urticaria caused by phenoxyethanol in ultrasound gel. Contact Dermatitis 2019; 81:132-133. [DOI: 10.1111/cod.13255] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2019] [Accepted: 02/26/2019] [Indexed: 11/30/2022]
Affiliation(s)
| | - Nagore Arruti
- Department of AllergologyHospital de Zumarraga Zumarraga Spain
| | - Alejandro Joral
- Department of AllergologyHospital Universitario de Donostia San Sebastian Spain
| | - Eva M. Lasa
- Department of AllergologyHospital Universitario de Donostia San Sebastian Spain
| | - Sara Martínez
- Department of AllergologyHospital Universitario de Donostia San Sebastian Spain
| | | |
Collapse
|
31
|
Taboada M, Soto-Jove R, Mirón P, Martínez S, Rey R, Ferreiroa E, Almeida X, Álvarez J, Baluja A. Evaluation of the laryngoscopy view using the modified Cormack-Lehane scale during tracheal intubation in an intensive care unit. A prospective observational study. ACTA ACUST UNITED AC 2019; 66:250-258. [PMID: 30862397 DOI: 10.1016/j.redar.2019.01.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2018] [Revised: 12/17/2018] [Accepted: 01/08/2019] [Indexed: 01/06/2023]
Abstract
BACKGROUND AND OBJECTVIES Tracheal intubation in the Intensive Care Unit is associated with a high incidence of difficult intubation and complications. This may be due to a poor view of the glottis during direct laryngoscopy. The aim of this study is to determine if there is a relationship between laryngoscopy view using the modified Cormack-Lehane scale with the incidence of difficult intubation and complications. METHODS All patients who were subjected to tracheal intubated with direct laryngoscopy in the Intensive Care Unit over a 45 month period were included in the study. In all patients, an evaluation was made of the laryngoscopy view using the modified Cormack-Lehane scale, as well as the technical difficulty (number of intubations at first attempt, operator-reported difficulty, need for a Frova introducer), and the incidence of complications (hypotension, hypoxia, oesophageal intubation). RESULTS A total of 360 patients were included. When the grade of the modified Cormack-Lehane scale was increased from 1 to 4, the incidence of first success rate intubation decreased (1: 97%, 2a: 94%, 2b: 80%, 3: 60%, 4: 0%, p<.001), the incidence of moderate and severe difficulty intubation increased (1: 2%, 2a: 4%, 2b: 36%, 3: 77%, 4: 100%, p<.001.), as well as the need for a Frova guide (1: 7%, 2a: 8%, 2b: 45%, 3: 60%, 4: 100%, p<.001). When the grade of the modified Cormack-Lehane scale increased from 1 to 4, the incidence of hypoxia<90% increased (1: 20%, 2a: 20%, 2b: 28%, 3: 47%, 4: 100%, p=.0073), as well as hypoxia<80% (1: 11%, 2a: 10%, 2b: 12%, 3: 27%, 4: 100%, p=.00398). No relationship was observed between the incidence of hypotension and the grade of the modified Cormack-Lehane scale (p=ns). CONCLUSIONS During tracheal intubation in the Intensive Care Unit a close relationship was found between a poor laryngoscopy view using the modified Cormack-Lehane scale and a higher difficulty technique of intubation. A relationship was found between the incidence of hypoxia with a higher grade in the modified Cormack-Lehane scale. No relationship was found between hypotension and the modified Cormack-Lehane scale.
Collapse
Affiliation(s)
- M Taboada
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España.
| | - R Soto-Jove
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| | - P Mirón
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| | - S Martínez
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| | - R Rey
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| | - E Ferreiroa
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| | - X Almeida
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| | - J Álvarez
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| | - A Baluja
- Grupo de Investigación Enfermo Crítico, Unidad de Cuidados Críticos, Servicio de Anestesiología, Hospital Clínico Universitario de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria, Santiago de Compostela, A Coruña, España
| |
Collapse
|
32
|
Martínez S, Lasa EM, Joral A, Infante S, Perez R, Ibáñez MD. Recommendations for the Use of Propofol in Egg-Allergic Patients. J Investig Allergol Clin Immunol 2019; 29:72-74. [DOI: 10.18176/jiaci.0337] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
33
|
Polunchenko AS, Martínez S, Martín JS. A Note on the Quasi-stationary Distribution of the Shiryaev Martingale on the Positive Half-Line. Theory Probab Appl 2019. [DOI: 10.1137/s0040585x97t989179] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
34
|
Ruiz-Muñoz M, Cordero-Bueso G, Martínez S, Pérez F, Hughes-Herrera D, Izquierdo-Bueno I, Cantoral J. The veil of flor's structure, composition and interactions in biological ageing wines. BIO Web Conf 2019. [DOI: 10.1051/bioconf/20191502018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Biological ageing occurs after fermentation of the grape must and it is due to the appearance of a biofilm on the surface of the wine called “veil of flor”. Yeast involved in veil formation are mainly Saccharomyces cerevisiae and they have traditionally been divided into four races according to their ability to metabolize different sugars. The growth of flor yeasts depends on different factors, such as the aerobic assimilation of the wine ethanol, since the medium is deficient in both sugars and nitrogen. Actually, flor yeast metabolism is different from wine S. cerevisiaeyeast, but it hasn't been analysed yet. Thus, the aim of this work is to study the diversity of flor yeast strains and to analyse the composition and the structure of the veil of flor in Jerez-Xérés-Sherry D.O. The results of this work revealed 14 different genotypes of S. cerevisiaestrains using multiplex-microsatellite PCR and these strains showed 8 different biochemical profiles using a similar procedure than traditionally. In addition, mannose and glucose were found in veil of flor complex using UHPLC-MS.
Collapse
|
35
|
Pacreu S, Martínez S, Vilà E, Moltó L, Fernández-Candil J. Dexmedetomidine in difficult airway management with a fibre-optic bronchoscope in the awake patient with Klippel-Feil Syndrome. Rev Esp Anestesiol Reanim (Engl Ed) 2018; 65:537-540. [PMID: 29887292 DOI: 10.1016/j.redar.2018.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/22/2018] [Revised: 05/04/2018] [Accepted: 05/06/2018] [Indexed: 06/08/2023]
Abstract
Klippel-Feil Syndrome is a disease characterised by congenital fusion of cervical vertebra, which leads to cervical limitation and instability. In these cases, the best option is the orotracheal intubation with the fibre-optic bronchoscope with the patient awake. The advantage is that cervical movements that could lead to neurological damage are minimised. In these patients, adequate sedation, together with instillation of local anaesthetic in the pharynx and hypopharynx, is the key to reducing patient discomfort and achieving successful orotracheal intubation. Dexmedetomidine is a selective α2- adrenergic receptor agonist that produces sedation and analgesia at the locus coeruleus without producing respiratory depression, as well as maintaining patient collaboration. The case is presented of a patient with Klippel-Feil Syndrome and difficult airway management, who was given a dexmedetomidine infusion at 0.6μg/kg/h as sedation for an awake fibre-optic endotracheal intubation.
Collapse
Affiliation(s)
- S Pacreu
- Servicio de Anestesiología, Reanimación y Terapia del dolor, Parc de Salut Mar, Barcelona, España.
| | - S Martínez
- Servicio de Anestesiología, Reanimación y Terapia del Dolor, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - E Vilà
- Servicio de Anestesiología, Reanimación y Terapia del dolor, Parc de Salut Mar, Barcelona, España
| | - L Moltó
- Servicio de Anestesiología, Reanimación y Terapia del dolor, Parc de Salut Mar, Barcelona, España
| | - J Fernández-Candil
- Servicio de Anestesiología, Reanimación y Terapia del dolor, Parc de Salut Mar, Barcelona, España
| |
Collapse
|
36
|
Tarrago M, Garcia-Valles M, Martínez S, Neuville DR. Phosphorus solubility in basaltic glass: Limitations for phosphorus immobilization in glass and glass-ceramics. J Environ Manage 2018; 220:54-64. [PMID: 29758399 DOI: 10.1016/j.jenvman.2018.04.079] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Revised: 04/11/2018] [Accepted: 04/18/2018] [Indexed: 06/08/2023]
Abstract
The composition of sewage sludge from urban wastewater treatment plants is simulated using P-doped basalts. Electron microscopy analyses show that the solubility of P in the basaltic melt is limited by the formation of a liquid-liquid immiscibility in the form of an aluminosilicate phase and a Ca-Mg-Fe-rich phosphate phase. The rheological behavior of these compositions is influenced by both phase separation and nanocrystallization. Upon a thermal treatment, the glasses will crystallize into a mixture of inosilicates and spinel-like phases at low P contents and into Ca-Mg-Fe phosphate at high P contents. Hardness measurements yield values between 5.41 and 7.66 GPa, inside the range of commercial glasses and glass-ceramics. Leaching affects mainly unstable Mg2+-PO43- complexes.
Collapse
Affiliation(s)
- M Tarrago
- Dept. Mineralogia, Petrologia i Geologia Aplicada, Facultat de Ciències de la Terra, Universitat de Barcelona, c/Martí i Franquès, s/n, 08028 Barcelona, Spain; CNRS-Institut de Physique du Globe de Paris, USPC, 1 rue Jussieu, 75005 Paris, France.
| | - M Garcia-Valles
- Dept. Mineralogia, Petrologia i Geologia Aplicada, Facultat de Ciències de la Terra, Universitat de Barcelona, c/Martí i Franquès, s/n, 08028 Barcelona, Spain
| | - S Martínez
- Dept. Mineralogia, Petrologia i Geologia Aplicada, Facultat de Ciències de la Terra, Universitat de Barcelona, c/Martí i Franquès, s/n, 08028 Barcelona, Spain
| | - D R Neuville
- CNRS-Institut de Physique du Globe de Paris, USPC, 1 rue Jussieu, 75005 Paris, France
| |
Collapse
|
37
|
Durà Mata M, Molleda Marzo M, Teixidor P, Caceres C, Enseñat A, Boldó M, Martínez S, Sanchez-Carrion R, Ruiz-Almazán I, Balaña C, Villà S. Randomized controlled trial on the impact of cognitive telerehabilitation on cognition and quality of life in glioma patients. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Esteban I, Vilaró M, Adrover E, Angulo A, Carrasco E, Gadea N, Sánchez A, Ocaña T, Llort G, Jover R, Cubiella J, Servitja S, Herráiz M, Cid L, Martínez S, Oruezábal-Moreno MJ, Garau I, Khorrami S, Herreros-de-Tejada A, Morales R, Cano JM, Serrano R, López-Ceballos MH, González-Santiago S, Juan-Fita MJ, Alonso-Cerezo C, Casas A, Graña B, Teulé A, Alba E, Antón A, Guillén-Ponce C, Sánchez-Heras AB, Alés-Martínez JE, Brunet J, Balaguer F, Balmaña J. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology 2018; 27:1530-1537. [PMID: 29498768 DOI: 10.1002/pon.4686] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2017] [Revised: 01/16/2018] [Accepted: 02/16/2018] [Indexed: 11/10/2022]
Abstract
OBJECTIVE Patients' psychological reactions to multigene cancer panel testing might differ compared with the single-gene testing reactions because of the complexity and uncertainty associated with the different possible results. Understanding patients' preferences and psychological impact of multigene panel testing is important to adapt the genetic counselling model. METHODS One hundred eighty-seven unrelated patients with clinical suspicion of hereditary cancer undergoing a 25-gene panel test completed questionnaires after pretest genetic counselling and at 1 week, 3 months, and 12 months after results to elicit their preferences regarding results disclosure and to measure their cancer worry and testing-specific distress and uncertainty. RESULTS A pathogenic variant was identified in 38 patients (34 high penetrance and 4 moderate penetrance variants), and 54 patients had at least one variant of uncertain significance. Overall, cancer panel testing was not associated with an increase in cancer worry after results disclosure (P value = .87). Twelve months after results, carriers of a moderate penetrance variant had higher distress and uncertainty scores compared with carriers of high penetrance variants. Cancer worry prior to genetic testing predicted genetic testing specific distress after results, especially at long term (P value <.001). Most of the patients reported the wish to know all genetic results. CONCLUSIONS Our results suggest that patients can psychologically cope with cancer panel testing, but distress and uncertainty observed in carriers of moderate penetrance cancer variants in this cohort warrant further research.
Collapse
Affiliation(s)
- I Esteban
- Hereditary Cancer Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain.,Genetics Department, Universidad Autònoma de Barcelona, Barcelona, Spain
| | - M Vilaró
- Oncology Data Science, Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - E Adrover
- Medical Oncology Department, Hospital General de Albacete, Albacete, Spain
| | - A Angulo
- Myriad Genetics Spain, Alcobendas, Spain
| | - E Carrasco
- Hereditary Cancer Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - N Gadea
- Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain
| | - A Sánchez
- Gastroenterology Department, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd)-Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain
| | - T Ocaña
- Gastroenterology Department, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd)-Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain
| | - G Llort
- Medical Oncology Department, Hospital Sabadell-Parc Taulí, Sabadell, Spain
| | - R Jover
- Gastroenterlogy Department, Hospital General Universitario de Alicante, Alicante, Spain
| | - J Cubiella
- Gastroenterology Department, Complejo Hospitalario Universitario de Ourense, Instituto de Investigación Sanitaria Galicia Sur, CIBERehd, Ourense, Spain
| | - S Servitja
- Medical Oncology Department, Hospital del Mar, Barcelona, Spain
| | - M Herráiz
- Gastroenterology Department, Clínica Universidad de Navarra, Pamplona, Spain
| | - L Cid
- Gastroenterology Department, Instituto Investigación Biomédica, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | - S Martínez
- Medical Oncology Department, Hospital de Mataró, Madrid, Spain
| | | | - I Garau
- Medical Oncology Department, Hospital Son Llatzer, Palma de Mallorca, Spain
| | - S Khorrami
- Gastroenterology Department, Hospital Son Espases, Palma de Mallorca, Spain
| | - A Herreros-de-Tejada
- Gastroenterlogy Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - R Morales
- Medical Oncology Department, Hospital La Mancha Centro, Alcázar de San Juan, Spain
| | - J M Cano
- Medical Oncology Department, Hospital General de Ciudad Real, Ciudad Real, Spain
| | - R Serrano
- Medical Oncology Department, Hospital Reina Sofia de Córdoba, Córdoba, Spain
| | - M H López-Ceballos
- Medical Oncology Department, Hospital San Pedro de Alcántara, Cáceres, Spain
| | - S González-Santiago
- Medical Oncology Department, Hospital San Pedro de Alcántara, Cáceres, Spain
| | - M J Juan-Fita
- Medical Oncology Department, Instituto Valencia de Oncología, Valencia, Spain
| | | | - A Casas
- Medical Oncology Department, Hospital Virgen del Rocío de Sevilla, Seville, Spain
| | - B Graña
- Medical Oncology Department, Hospital Universitario de A Coruña, La Coruña, Spain
| | - A Teulé
- Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet, Spain
| | - E Alba
- Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - A Antón
- Medical Oncology Department, Hospital Miguel Servet de Zaragoza, Zaragoza, Spain
| | - C Guillén-Ponce
- Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain
| | - A B Sánchez-Heras
- Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain
| | - J E Alés-Martínez
- Medical Oncology Department, Hospital de Nuestra Señora de Sonsoles, Ávila, Spain
| | - J Brunet
- Hereditary Cancer Program, Catalan Institute of Oncology, IDIBGI, Girona, Spain
| | - F Balaguer
- Gastroenterology Department, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd)-Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain
| | - J Balmaña
- Hereditary Cancer Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain.,Genetics Department, Universidad Autònoma de Barcelona, Barcelona, Spain.,Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain
| |
Collapse
|
39
|
Lasa EM, González C, García-Lirio E, Martínez S, Arroabarren E, Gamboa PM. Anaphylaxis caused by immediate hypersensitivity to topical chlorhexidine in children. Ann Allergy Asthma Immunol 2017; 118:118-119. [PMID: 28007083 DOI: 10.1016/j.anai.2016.10.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2016] [Revised: 09/28/2016] [Accepted: 10/13/2016] [Indexed: 11/30/2022]
Affiliation(s)
- Eva María Lasa
- Servicio de Alergología, Hospital Universitario Donostia, San Sebastián, España.
| | - Carlos González
- Servicio de Alergología, Hospital Universitario de Basurto, Bilbao, España
| | | | - Sara Martínez
- Servicio de Alergología, Hospital Universitario Donostia, San Sebastián, España
| | - Esozia Arroabarren
- Servicio de Alergología, Complejo Hospitalario de Navarra, Pamplona, España
| | | |
Collapse
|
40
|
Armengol S, Manzano M, Bea SA, Martínez S. Identifying and quantifying geochemical and mixing processes in the Matanza-Riachuelo Aquifer System, Argentina. Sci Total Environ 2017; 599-600:1417-1432. [PMID: 28531951 DOI: 10.1016/j.scitotenv.2017.05.046] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Revised: 05/04/2017] [Accepted: 05/05/2017] [Indexed: 06/07/2023]
Abstract
The Matanza-Riachuelo River Basin, in the Northeast of the Buenos Aires Province, is one of the most industrialized and populated region in Argentina and it is worldwide known for its alarming environmental degradation. In order to prevent further damages, the aquifer system, which consists of two overlaid aquifers, is being monitored from 2008 by the river basin authority, Autoridad de la Cuenca Matanza-Riachuelo. The groundwater chemical baseline has been established in a previous paper (Zabala et al., 2016), and this one is devoted to the identification of the main physical and hydrogeochemical processes that control groundwater chemistry and its areal distribution. Thirty five representative groundwater samples from the Upper Aquifer and thirty four from the deep Puelche Aquifer have been studied with a multi-tool approach to understand the origin of their chemical and isotopic values. The resulting conceptual model has been validated though hydrogeochemical modeling. Most of the aquifer system has fresh groundwater, but some areas have brackish and salt groundwater. Water recharging the Upper Aquifer is of the Ca-HCO3 type as a result of soil CO2 and carbonate dissolution. Evapotranspiration plays a great role concentrating recharge water. After recharge, groundwater becomes Na-HCO3, mostly due to cation exchange with Na release and Ca uptake, which induces calcite dissolution. Saline groundwaters exist in the lower and upper sectors of the basin as a result of Na-HCO3 water mixing with marine water of different origins. In the upper reaches, besides mixing with connate sea water other sources of SO4 exist, most probably gypsum and/or sulfides. This work highlights the relevance of performing detailed studies to understand the processes controlling groundwater chemistry at regional scale. Moreover, it is a step forward in the knowledge of the aquifer system, and provides a sound scientific basis to design effective management programs and recovery plans.
Collapse
Affiliation(s)
- S Armengol
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Av. Rivadavia 1917, C1033AAJ Ciudad Autónoma de Buenos Aires, Argentina; Instituto de Hidrología de Llanuras "Dr. Eduardo J. Usunoff", Av. República Italia 780, 7300 Azul, Buenos Aires, Argentina.
| | - M Manzano
- Escuela de Ingeniería de Caminos, Canales y Puertos y de Ingeniería de Minas, Universidad Politécnica de Cartagena, P° de Alfonso XIII 52, E-30203 Cartagena, Spain
| | - S A Bea
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Av. Rivadavia 1917, C1033AAJ Ciudad Autónoma de Buenos Aires, Argentina; Instituto de Hidrología de Llanuras "Dr. Eduardo J. Usunoff", Av. República Italia 780, 7300 Azul, Buenos Aires, Argentina
| | - S Martínez
- Autoridad de Cuenca Matanza Riachuelo (ACUMAR), Esmeralda 255 PB, C1033AAJ Ciudad Autónoma de Buenos Aires, Argentina
| |
Collapse
|
41
|
Cardona A, Martínez S, Arrieta O, Serna A, Barrios R, Garzón J, Navarrete C, Balaguera A, Reyes O, Galvis D, Zatarain-Barron Z, Rojas L. P3.08-005 Hereditary Familial Overlap Syndrome with Multiple Synchronous Lung Tumors. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
42
|
Ramos J, Álvarez-Bustos A, Soriano M, Nuñez B, Ros J, Osorio P, Gutierrez L, Gómez R, Hidalgo F, Leon A, Mendez M, González C, Sanchez A, Martínez S, Pagola I, Brea L, Fiuza-Luces C, Lucia A, Ruiz-Casado A. Ideal cardiovascular health (ICVH) in patients with a recent diagnosis of colorectal cancer (CRC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx388.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL. Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study. Osteoporos Int 2017; 28:2457-2464. [PMID: 28466136 DOI: 10.1007/s00198-017-4062-8] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2017] [Accepted: 04/17/2017] [Indexed: 01/07/2023]
Abstract
UNLABELLED Determination of different forms of 25-OHD (total, free and bioavailable) in healthy young women does not offer additional advantages over standard 25-OHDT for evaluating vitamin D deficiency. In these subjects 25-OHDT values <15 ng/ml would be more appropriate for defining this deficiency. INTRODUCTION Determination of 25-OH vitamin D serum levels (25-OHD) constitutes the method of choice for evaluating vitamin D deficiency. However, vitamin D-binding protein (DBP) may modulate its bioavailability thereby affecting correct evaluation of 25-OHD status. We analysed the impact of the determination of 25-OHD (total, free and bioavailable) on the evaluation its biologic activity (estimated by serum PTH determination) in healthy young women. METHODS 173 premenopausal women (aged 35-45 yrs.) were included. We analysed serum values of total 25-OHD (25-OHDT), DBP, albumin, PTH and bone formation (PINP,OC) and resorption (NTx,CTx) markers. Free(25-OHDF) and bioavailable (25-OHDB) serum 25-OHD levels were estimated by DBP and albumin determinations and also directly by ELISA (25-OHDF-2). We analysed threshold PTH values for the different forms of 25-OHD and the correlations and differences according to 25-OHDT levels <20 ng/ml. RESULTS 62% of subjects had 25-OHD values <20 ng/ml and also had significantly lower 25-OHDF and 25-OHDB values, with no significant differences in bone markers and PTH values. The PTH threshold value was similar for all forms of 25-OHD (∼70 pg/ml). Women with PTH values >70 had lower 25-OHDT (15.4 ± 1.4 vs. 18.3 ± 2.7, p < 0.05) and 25OHDB values (1.7 ± 0.2 vs. 2.2 ± 0.09, p < 0.05). The different forms of 25OHD were significantly intercorrelated, with marginal correlations between PTH and 25-OHDT (r = -0.136, p = 0.082). CONCLUSIONS Determination of different forms of 25-OHD in healthy young women does not offer additional advantages over standard 25-OHDT for evaluating vitamin D deficiency. In these subjects 25-OHDT values <15 ng/ml would be more appropriate for defining this deficiency.
Collapse
Affiliation(s)
- P Peris
- Hospital Clínic de Barcelona, IDIBAPS. CIBERehd, Barcelona, Spain.
| | - X Filella
- Servicio de Bioquímica Clínica, Hospital Clinic, Barcelona, Spain
| | - A Monegal
- Hospital Clínic de Barcelona, IDIBAPS. CIBERehd, Barcelona, Spain
| | - N Guañabens
- Hospital Clínic de Barcelona, IDIBAPS. CIBERehd, Barcelona, Spain
| | - L Foj
- Servicio de Bioquímica Clínica, Hospital Clinic, Barcelona, Spain
| | - M Bonet
- Hospital de l'Alt Penedés, Barcelona, Spain
| | - D Boquet
- Hospital Arnau de Vilanova, Lleida, Spain
| | - E Casado
- Instituto Universitario Parc Taulí, Barcelona, Spain
| | - D Cerdá
- Hospital Moisés Broggi, Barcelona, Spain
| | - A Erra
- Hospital Universitari de Bellvitge, Barcelona, Spain.
| | | | - S Martínez
- Hospital Mútua de Terrassa, Madrid, Spain
| | - N Montalá
- Hospital Sta María, Barcelona, Spain
| | | | | | - M Sala
- Hospital de Figueres, Barcelona, Spain
| | - X Suris
- Hospital de Ganollers, Catalonia, Spain
| | - J L Carrasco
- Departament de Fonaments Clínics, Universitat de Barcelona, Barcelona, Spain
| | | |
Collapse
|
44
|
Pouessel G, Claverie C, Labreuche J, Renaudin JM, Dorkenoo A, Eb M, Moneret-Vautrin A, Deschildre A, Leteurtre S, Grabenhenrich L, Worm M, Dölle S, Scherer K, Hutteger I, Christensen M, Bindslev-Jensen C, Mortz C, Eller E, Kjaer HF, Carneiro-Leão L, Badas J, Coimbra A, Levy DP, Ben-Shoshan M, Rimon A, Benor S, Arends NJT, Edelbroek N, de Groot H, Emons JAM, Brand HKA, Verhoeven D, van Veen LN, de Jong NW, Noh G, Jang EH, Pascal M, Dominguez O, Piquer M, Alvaro M, Jimenez-Feijoo R, Lozano J, Machinena A, del Mar Folqué M, Giner MT, Plaza AM, Turner P, Patel N, Vazquez-Ortiz M, Lindsley S, Walker L, Rosenberg S, Mari A, Alessandri C, Giangrieco I, Tuppo L, Rafaiani C, Mitterer G, Ciancamerla M, Ferrara R, Bernardi ML, Zennaro D, Tamburrini M, Ciardiello MA, Harwanegg C, Fernandez A, Selb R, Egenmann P, Epstein M, Hoffmann-Sommergruber K, Koning F, Lovik M, Clare Mills EN, Moreno J, van Loveren H, Wal JM, Diesner S, Bergmayr C, Pfitzner B, Assmann VE, Starkl P, Endesfelder D, Eiwegger T, Szepfalusi Z, Fehrenbach H, Jensen-Jarolim E, Hartmann A, Pali-Schöll I, Untersmayr E, Wille S, Meyer P, Klingebiel C, Lidholm J, Ehrenberg A, Östling J, Cleach I, Mège JL, Vitte J, Aina R, Dubiela P, Pfeifer S, Bublin M, Radauer C, Humeniuk P, Kabasser S, Asero R, Bogas G, Gomez F, Campo P, Salas M, Doña I, Barrionuevo E, Guerrero MA, Mayorga C, Prieto A, Barber D, Torres MJ, Jamin A, Wangorsch A, Ballmer B, Vieths S, Scheurer S, Apostolovic D, Mihailovic J, Krstic M, Starkhammar M, Velickovic TC, Hamsten C, van Hage M, van Erp FC, Knol EF, Kansen HM, Pontoppidan B, Meijer Y, van der Ent CK, Knulst AC, Sayers R, Brown H, Custovic A, Simpson A, Mills C, Schulz J, Akkerdaas J, Totis M, Capt A, Herouet-Guicheney C, van Ree R, Banerjee T, Banerjee A, Claude M, Bouchaud G, Lupi R, Castan L, Tranquet O, Denery-Papini S, Bodinier M, Brossard C, De Poi R, Gritti E, De Dominicis E, Popping B, de Laureto PP, Palosuo K, Kukkonen AK, Pelkonen A, Mäkelä M, Lee NA, Rost J, Muralidharan S, Campbell D, Mehr S, Nock C, Baumert J, Taylor S, Mastrorilli C, Tripodi S, Caffarelli C, Perna S, Di Rienzo Businco A, Sfika I, Dondi A, Bianchi A, Dascola CP, Ricci G, Cipriani F, Maiello N, del Giudice MM, Frediani T, Frediani S, Macrì F, Pistoletti C, Iacono ID, Patria MF, Varin E, Peroni D, Comberiati P, Chini L, Moschese V, Lucarelli S, Bernardini R, Pingitore G, Pelosi U, Olcese R, Moretti M, Cirisano A, Faggian D, Travaglini A, Plebani M, Verga MC, Calvani M, Giordani P, Matricardi PM, Ontiveros N, Cabrera-Chavez F, Galand J, Beaudouin E, Pineau F, Sakai S, Matsunaga K, Teshima R, Larré C, Denery S, Tschirner S, Trendelenburg V, Schulz G, Niggemann B, Beyer K, Bouferkas Y, Belabbas Y, Saidi D, Kheroua O, Mecherfi KEE, Guendouz M, Haddi A, Kaddouri H, Amaral L, Pereira A, Rodrigues S, Datema M, Jongejan L, Clausen M, Knulst A, Papadopoulos N, Kowalski M, de Blay F, Zwinderman A, Hoffman-Sommergruber K, Ballmer-Weber B, Fernandez-Rivas M, Deng S, Yin J, Eisenmann C, Nassiri M, Reinert R, van der Valk JPM, van Wijk RG, Vergouwe Y, Steyerberg EW, Reitsma M, Wichers HJ, Savelkoul HFJ, Vlieg-Boerstra B, Dubois AEJ, de Jong NW, Carolino F, Rodolfo A, Cernadas J, Roa-Medellín D, Rodriguez-Fernandez A, Navarro J, Albendiz V, Baeza ML, Intente-Herrero S, Mikkelsen A, Mehlig K, Lissner L, Verrill L, Luccioli S, van Bilsen J, Kuper F, Wolterbeek A, Rankouhi TR, Verschuren L, Cnossen H, Jeurink P, Garssen J, Knippels L, Garthoff J, Houben G, Leeman W, Eleonore Pettersson M, Schins AMM, Koppelman GH, Kollen BJ, Zubchenko S, Kuntz S, Mérida P, Álvaro M, Piquer M, Riggioni C, Castellanos JH, Jimenez R, Cap M, Drumez E, Lejeune S, Thumerelle C, Mordacq C, Nève V, Ricò S, Varini M, Nocerino R, Cosenza L, Amoroso A, Di Costanzo M, Di Scala C, Bedogni G, Canani RB, Turner PJ, Poza-Guedes P, González-Pérez R, Sánchez-Machín I, Matheu-Delgado V, Wambre E, Ballegaard AS, Madsen C, Gregersen J, Bøgh KL, Aubert P, Neunlist M, Magnan A, Lozano-Ojalvo D, Pablos-Tanarro A, Pérez-Rodríguez L, Molina E, López-Fandiño R, Rekima A, Macchiaverni P, Turfkruyer M, Holvoet S, Dupuis L, Baiz N, Annesi-Maesano I, Mercenier A, Nutten S, Verhasselt V, Mrakovcic-Sutic I, Banac S, Sutic I, Baricev-Novakovic Z, Sutic I, Pavisic V, Muñoz-Cano R, Jiménez-Rodríguez T, Corbacho D, Roca-Ferrer J, Bartra J, Bulog A, Micovic V, Markiewicz L, Szymkiewicz A, Szyc A, Wróblewska B, Harvey BM, Harthoorn LF, Wesley Burks A, Rentzos G, Björk ALB, Bengtsson U, Barber C, Kalicinsky C, Breynaert C, Coorevits L, Jansen C, Van Hoeyveld E, Verbeke K, Kochuyt AM, Schrijvers R, Deleanu D, Muntean A, Konstantakopoulou M, Pasioti M, Papadopoulou A, Iliopoulou A, Mikos N, Kompoti E, de Castro ED, Bartalomé B, Ue KL, Griffiths E, Till S, Grimshaw K, Roberts G, Selby A, Butiene I, Larco JI, Dubakiene R, Fiandor A, Fiocchi A, Papadopoulos N, Sigurdardottir S, Sprikkelman A, Schoemaker AF, Xepapadaki P, Keil T, Cojocariu Z, Barbado BS, Iancu V, Arroabarren E, Esarte MG, Arteaga M, Andrade MC, Borges D, Kalil J, Bianchi PG, Agondi RC, Gupta RK, Sharma A, Gupta K, Das M, Dwivedi P, Karseladze R, Jorjoliani L, Saginadze L, Tskhakaia M, Basello K, Piuri G, Speciani AF, Speciani MC, Camerotto C, Zinno F, Pakholchuk O, Nedelska S, Pattini S, Costantino MT, Peveri S, Villalta D, Savi E, Costanzi A, Revyakina VA, Kiseleva MA, Kuvshinova ED, Larkova IA, Shekhetov AA, Silva D, Moreira A, Plácido J, van der Kleij H, van Twuijver E, Sutorius R, de Kam PJ, van Odijk J, Lindqvist H, Lustig E, Jácome AAA, Aguilar KLB, Domínguez MG, Hernández DAM, Caruso C, Casale C, Rapaccini GL, Romano A, De Vitis I, Cocco RR, Aranda C, Mallozi MC, Motta JF, Moraes L, Pastorino A, Rosario N, Goudouris E, Porto A, Wandalsen NF, Sarinho E, Sano F, Solé D, Pitsios C, Petrodimopoulou M, Papadopoulou E, Passioti M, Kontogianni M, Adamia N, Khaleva E, del Prado AP, Du Toit G, Krzych E, Samolinska-Zawisza U, Furmanczyk K, Tomaszewska A, Raciborski F, Lipiec A, Samel-Kowalik P, Walkiewicz A, Borowicz J, Samolinski B, Nano AL, Recto M, Somoza ML, López NB, Alzate DP, Ruano FJ, Garcimartín MI, Haroun E, de la Torre MV, Rojas A, Onieva ML, Canto G, Rodrigues A, Forno A, Cabral AJ, Gonçalves R, Vorozhko I, Sentsova T, Chernyak O, Denisova S, Ilènko L, Muhortnich V, Zimmermann C, Rohrbach A, Bakhsh FR, Boudewijn K, Oomkes-Pilon AM, Van Ginkle D, Šilar M, Jeverica A, Vesel T, Avčin T, Korošec P, van der Valk J, Berends I, Arends N, van Maaren M, Wichers H, Emons J, Dubois A, de Jong N, Matsyura O, Besh L, Huang CH, Jan TR, Stiefel G, Tratt J, Kirk K, Carolino F, Arasi S, Caminiti L, Crisafulli G, Fiamingo C, Fresta J, Pajno G, Remington B, Kruizinga A, Marty Blom W, Westerhout J, Bijlsma S, Baumert J, Blankestijn M, Otten H, Klemans R, Michelsen-Huisman AD, van Os-Medendorp H, Kruizinga AG, Versluis A, van Duijn G, de Zeeuw-Brouwer HML, Castenmiller JJM, Noteborn HPJM, Houben GF, Bravin K, Luyt D, Javed B, Couch P, Munro C, Padfield P, Sperrin M, Byrne A, Oosthuizen L, Kelleher C, Ward F, Brosnan N, King G, Corbet E, Guzmán JAH, García MB, Asensio O, Navarrete LV, Larramona H, Miró XD, Pyrz K, Austin M, Boloh Y, Couch P, Galloway D, Hernandez P, Hourihane JO, Kenna F, Majkowska-Wojciechowska B, Regent L, Themisb M, Schnadt S, Semic-Jusufagic A, Galvin AD, Kauppila T, Kuitunen M, Kitsioulis NA, Douladiris N, Kostoudi S, Manolaraki I, Mitsias D, Manousakis E, Papadopoulos NG, Knibb R, Hammond J, Cooke R, Yrjänä J, Hanni AM, Vähäsarja P, Mustonen O, Dunder T, Kulmala P, Lasa E, D’Amelio C, Martínez S, Joral A, Gastaminza G, Goikoetxea MJ, Candy DCA, Van Ampting MTJ, Oude Nijhuis MM, Butt AM, Peroni DG, Fox AT, Knol J, Michaelis LJ, Padua I, Padrao P, Moreira P, Barros R, Sharif H, Ahmed M, Gomaa N, Mens J, Smit K, Timmermans F, Poredoš T, Jeverica AK, Sedmak M, Benedik E, Accetto M, Zupančič M, Yonamine G, Soldateli G, Aquilante B, Pastorino AC, de Moraes Beck CL, Gushken AK, de Barros Dorna M, dos Santos CN, Castro APM, Al-Qahtani A, Arnaout R, Khaliq AR, Amin R, Sheikh F, Alvarez J, Anda M, Palacios M, De Prada M, Ponce C, Balbino B, Sibilano R, Marichal T, Gaudenzio N, Karasuyama H, Bruhns P, Tsai M, Reber LL, Galli SJ, Ferreira AR, Cernadas JR, del Campo García A, Fernández SP, Carrera NS, Sánchez-Cruz FB, Lorenzo JRF, Claus S, Pföhler C, Ruëff F, Treudler R, Jaume ME, Madroñero A, Perez MTG, Julia JC, Plovdiv CH, Gethings L, Langridge J, Adel-Patient K, Bernard H, Barcievic-Jones I, Sokolova R, Yankova R, Ivanovska M, Murdjeva M, Popova T, Dermendzhiev S, Karjalainen M, Lehnigk U, Brown D, Locklear JC, Locklear J, Maris I, Hourihane J, Ornelas C, Caiado J, Ferreira MB, Pereira-Barbosa M, Puente Y, Daza JC, Monteseirin FJ, Ukleja-Sokolowska N, Gawronska-Ukleja E, Zbikowska-Gotz M, Bartuzi Z, Sokolowski L, Adams A, Mahon B, English K, Gourdon-Dubois N, Sellam L, Pereira B, Michaud E, Messaoudi K, Evrard B, Fauquert JL, Palomares F, Gomez G, Rodriguez MJ, Galindo L, Molina A, Paparo L, Mennini M, Aitoro R, Wawrzeńczyk A, Przybyszewski M, Wawrzeńczyk A, Sarıcoban HE, Ugras M, Yalvac Z, Flokstra-de Blok BMJ, van der Velde JL, Vereda A, Ippolito C, Traversa A, Adriano D, Bianchi DM, Gallina S, Decastelli L, Makatsori M, Miles A, Devetak SP, Devetak I, Tabet SA, Trandbohus JF, Winther P, Malling HJ, Hansen KS, Garvey LH, Wang CC, Cheng YH, Tung CW, Dietrich M, Marenholz I, Kalb B, Grosche S, Blümchen K, Schlags R, Price M, Rietz S, Esparza-Gordillo J, Lau S, Lee YA, Almontasheri A, Bahkali MA, Elshorbagi S, Alfhaid A, Altamimi M, Madbouly E, Al-Dhekri H, Arnaout RK, Basagaña M, Miquel S, Bartolomé B, Brix B, Rohwer S, Brandhoff S, Berger A, Suer W, Weimann A, Bueno C, Martín-Pedraza L, Abián S, Segundo-Acosta PS, López-Rodríguez JC, Barderas R, Batanero E, Cuesta-Herranz J, Villalba MT, Correia M, Benito-Garcia F, Arêde C, Piedade S, Morais-Almeida M, Hindley J, Yarham R, Kuklinska-Pijanka A, Gillick D, Patient K, Chapman MD, Bøgh KL, Miranda A, Matos E, Sokolova A, Rao H, Baricevic-Jones I, Smith F, Xue W, Magnusdottir H, Vidarsdottir AG, Lund S, Jensen AB, Ludviksson BR, Simon R, Elfont R, Bennett S, Voyksner R, de Lurdes Torre M, Yürek S, Faber MA, Bastiaensen A, Mangodt E, van Gasse A, Decuyper I, Sabato V, Hagendorens MM, Bridts CH, De Clerck LS, Ebo D, Schwarz S, Ziegert M, Albroscheit S, Schwager C, Kull S, Behrends J, Röckendorf N, Schocker F, Frey A, Homann A, Becker WM, Jappe U, Zaabat N, Osscini S, Agabriel C, Sterling B, Carsin A, Liabeuf V, Maćków M, Zbróg A, Bronkowska M, Courtois J, Gadisseur R, Bertholet C, Lukas P, Cavalier E, Delahaut P, Quinting B, Gertmo MB, Hasseus ET, Barzylovych V, Oliveira J, Ensina LF, Aranda CS, Dopazo L, Lopez R, Perez R, Santos-Diez L, Bilbao A, Garcia JM, Núñez IG, Mármol MÁA, Villarejo MJB, Martos JAB, Vergara MS, García JMI, Michalska A, Sergiejko G, Zacniewski R, Ghiordanescu IM, Deaconu C, Popescu M, Bumbacea RS, Ibranji A, Nikolla E, Loloci G, Juel-Berg N, Larsen LF, Poulsen LK, Marcelino J, Prata R, Costa AC, Duarte F, Neto M, Santos J, Pestana LC, Sampaio D, Minale P, Dignetti P, Bignardi D, Nedelea I, Popescu FD, Vieru M, Secureanu FA, Ganea CS, Vieira M, Silva JPM, Watts T, Watts S, Lomikovska M, Peredelskaya M, Nenasheva N, Filipovic I, Zivkovic Z, Filipovic D, Higgs J, Warner A, Jones C. Abstracts from the Food Allergy and Anaphylaxis Meeting 2016. Clin Transl Allergy 2017. [PMCID: PMC5384531 DOI: 10.1186/s13601-017-0142-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
|
45
|
Cancino P, Paredes-García V, Torres J, Martínez S, Kremer C, Spodine E. {[Cu3Lu2(ODA)6(H2O)6]·10H2O}n: the first heterometallic framework based on copper(ii)/lutetium(iii) for the catalytic oxidation of olefins and aromatic benzylic substrates. Catal Sci Technol 2017. [DOI: 10.1039/c7cy01385j] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The catalytic performance of the novel framework {[Cu3Lu2(ODA)6(H2O)6]·10H2O}n was tested in the oxidation of alkenes and benzylic hydrocarbons, using tert-butyl hydroperoxide (TBHP) and molecular oxygen (O2) as oxidants.
Collapse
Affiliation(s)
- P. Cancino
- Facultad de Ciencias Químicas y Farmacéuticas
- Universidad de Chile
- Santiago
- Chile
- Centro para el Desarrollo de la Nanociencia y la Nanotecnología
| | - V. Paredes-García
- Centro para el Desarrollo de la Nanociencia y la Nanotecnología
- CEDENNA
- Santiago
- Chile
- Departamento de Ciencias Exactas
| | - J. Torres
- Departamento Estrella Campos
- Facultad de Química
- Universidad de la República
- Montevideo
- Uruguay
| | - S. Martínez
- Departamento Estrella Campos
- Facultad de Química
- Universidad de la República
- Montevideo
- Uruguay
| | - C. Kremer
- Departamento Estrella Campos
- Facultad de Química
- Universidad de la República
- Montevideo
- Uruguay
| | - E. Spodine
- Facultad de Ciencias Químicas y Farmacéuticas
- Universidad de Chile
- Santiago
- Chile
- Centro para el Desarrollo de la Nanociencia y la Nanotecnología
| |
Collapse
|
46
|
Romero I, Rubio M, Serrano R, Medina M, Minig L, Casado A, Coronado P, Martínez S, Orbegoso C, Fusté P, Alia EG, Sánchez-Martínez M, Rubio D, Santacana M, Ruiz M, Llombart-Cussac A, Matias-Guiu X, Poveda A. Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw374.50] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Carrera D, de la Flor M, Galera J, Amillano K, Gomez M, Izquierdo V, Aguilar E, López S, Martínez M, Martínez S, Serra J, Pérez M, Martin L. Validación de la biopsia selectiva del ganglio centinela en mujeres con cáncer de mama N1-2 con respuesta axilar completa tras la neoadyuvancia. Estudio multicéntrico en la provincia de Tarragona. Rev Esp Med Nucl Imagen Mol 2016; 35:221-5. [DOI: 10.1016/j.remn.2015.12.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2015] [Revised: 12/14/2015] [Accepted: 12/19/2015] [Indexed: 02/06/2023]
|
48
|
Ferreiro T, Martínez S, Gayoso L, Rodríguez-Otero JL. Evolution of phospholipid contents during the production of quark cheese from buttermilk. J Dairy Sci 2016; 99:4154-4159. [PMID: 27060823 DOI: 10.3168/jds.2016-10861] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Accepted: 03/02/2016] [Indexed: 11/19/2022]
Abstract
We report the evolution of phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylcholine (PC), phosphatidylserine (PS), and sphingomyelin (SM) contents during the production of quark cheese from buttermilk by successive ultrafiltration concentration, enrichment with cream, concurrent homogenization and pasteurization, fermentative coagulation, and separation of quark from whey by further ultrafiltration. Buttermilk is richer than milk itself in phospholipids that afford desirable functional and technological properties, and is widely used in dairy products. To investigate how phospholipid content is affected by end-product production processes such as ultrafiltration, homogenization, pasteurization or coagulation, we measured the phospholipids at several stages of each of 5 industrial-scale quark cheese production runs. In each run, 10,000L of buttermilk was concentrated to half volume by ultrafiltration, enriched with cream, homogenized, pasteurized, inoculated with lactic acid bacteria, incubated to coagulation, and once more concentrated to half volume by ultrafiltration. Phospholipid contents were determined by HPLC with evaporative light scattering detection in the starting buttermilk, concentrated buttermilk, ultrafiltrate, cream-enriched concentrated buttermilk (both before and after concurrent homogenization and pasteurization), coagulate, and quark, and also in the rinsings obtained when the ultrafiltration equipment was washed following initial concentration. The average phospholipid content of buttermilk was approximately 5 times that of milk, and the phospholipid content of buttermilk fat 26 to 29 times that of milk fat. Although phospholipids did not cross ultrafiltration membranes, significant losses occurred during ultrafiltration (due to retention on the membranes) and during the homogenization and pasteurization process. During coagulation, however, phospholipid content rose, presumably as a consequence of the proliferation of the inoculated lactic acid bacteria. In spite of these changes in total phospholipid content, the relative proportions of the phospholipids studied remain fairly stable throughout quark production (PE>PC>SM>PS>PI) and similar to those found in the milk of the region, except that SM content was lower than in milk.
Collapse
Affiliation(s)
- T Ferreiro
- Instituto de Investigación e Análises Aliimentarias, Universidade de Santiago de Compostela, Facultade de Veterinaria, 27002 Lugo, Spain
| | - S Martínez
- INNOLACT S.L. Poligono Industrial, Castro de Ribeiras de Lea, 27260 Lugo, Spain
| | - L Gayoso
- Instituto de Investigación e Análises Aliimentarias, Universidade de Santiago de Compostela, Facultade de Veterinaria, 27002 Lugo, Spain
| | - J L Rodríguez-Otero
- Instituto de Investigación e Análises Aliimentarias, Universidade de Santiago de Compostela, Facultade de Veterinaria, 27002 Lugo, Spain.
| |
Collapse
|
49
|
Biasato I, De Marco M, Rotolo L, Renna M, Lussiana C, Dabbou S, Capucchio MT, Biasibetti E, Costa P, Gai F, Pozzo L, Dezzutto D, Bergagna S, Martínez S, Tarantola M, Gasco L, Schiavone A. Effects of dietaryTenebrio molitormeal inclusion in free-range chickens. J Anim Physiol Anim Nutr (Berl) 2016; 100:1104-1112. [DOI: 10.1111/jpn.12487] [Citation(s) in RCA: 77] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2015] [Accepted: 01/10/2016] [Indexed: 11/28/2022]
Affiliation(s)
- I. Biasato
- Dipartimento di Scienze Veterinarie; Università degli Studi di Torino; Grugliasco Torino Italy
| | - M. De Marco
- Dipartimento di Scienze Veterinarie; Università degli Studi di Torino; Grugliasco Torino Italy
| | - L. Rotolo
- Dipartimento di Scienze Agrarie; Forestali e Alimentari; Università degli Studi di Torino; Grugliasco Torino Italy
| | - M. Renna
- Dipartimento di Scienze Agrarie; Forestali e Alimentari; Università degli Studi di Torino; Grugliasco Torino Italy
| | - C. Lussiana
- Dipartimento di Scienze Agrarie; Forestali e Alimentari; Università degli Studi di Torino; Grugliasco Torino Italy
| | - S. Dabbou
- Dipartimento di Scienze Agrarie; Forestali e Alimentari; Università degli Studi di Torino; Grugliasco Torino Italy
| | - M. T. Capucchio
- Dipartimento di Scienze Veterinarie; Università degli Studi di Torino; Grugliasco Torino Italy
| | - E. Biasibetti
- Dipartimento di Scienze Veterinarie; Università degli Studi di Torino; Grugliasco Torino Italy
| | - P. Costa
- Dipartimento di Scienze Veterinarie; Università degli Studi di Torino; Grugliasco Torino Italy
| | - F. Gai
- Istituto di Scienze delle Produzioni Alimentari (ISPA); CNR; Grugliasco Torino Italy
| | - L. Pozzo
- Istituto di Scienze delle Produzioni Alimentari (ISPA); CNR; Grugliasco Torino Italy
| | - D. Dezzutto
- Istituto Zooprofilattico Sperimentale del Piemonte; Liguria e Valle d'Aosta; Torino Italy
| | - S. Bergagna
- Istituto Zooprofilattico Sperimentale del Piemonte; Liguria e Valle d'Aosta; Torino Italy
| | - S. Martínez
- Departamento de Producción Animal; Universidad de Murcia; Murcia Spain
| | - M. Tarantola
- Dipartimento di Scienze Veterinarie; Università degli Studi di Torino; Grugliasco Torino Italy
- Istituto di Ricerche Interdisciplinari sulla Sostenibilità; Università degli Studi di Torino; Grugliasco Torino Italy
| | - L. Gasco
- Dipartimento di Scienze Agrarie; Forestali e Alimentari; Università degli Studi di Torino; Grugliasco Torino Italy
- Istituto di Scienze delle Produzioni Alimentari (ISPA); CNR; Grugliasco Torino Italy
| | - A. Schiavone
- Dipartimento di Scienze Veterinarie; Università degli Studi di Torino; Grugliasco Torino Italy
- Istituto di Ricerche Interdisciplinari sulla Sostenibilità; Università degli Studi di Torino; Grugliasco Torino Italy
| |
Collapse
|
50
|
Miarons M, Martínez S, García V, Marin S, Camps ML, Agustí C, Gurrera T. CP-208 Pegylated liposomal doxorubicin and carboplatine combination in the treatment of recurrent ovarian carcinoma. Comparative long term effectiveness. Eur J Hosp Pharm 2016. [DOI: 10.1136/ejhpharm-2016-000875.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|